Índice

• Symposia SES01. AEP section “Child psychiatry”: Antecedents and mechanisms of mental disorders during childhood and adolescence

  • ·SES01.01 Developmental precursors of affective illness in a general population birth cohort

    Página :213-213

    J. van Os, P. Jones, G. Lewis, M. Wadsworth, R. Murray

    
  • ·SES01.02 Population birth cohorts: Antecedents of schizophrenia

    Página :213-213

    P.B. Jones

    
  • ·SES01.03 Premorbid features of adolescents and young adults with schizophrenia

    Página :213-213

    B. Lahuis

    
  • ·SES01.04 Genesis and course of anxiety and conduct disorders from childhood to early adulthood

    Página :213-214

    M.H. Schmidt, W. Ihle, G. Esser, B. Blanz

    Resumen Resumen Esquema Esquema

• Symposia S01. The identity and future of psychiatry

  • ·S01.01 The focus and organization of future education

    Página :214-214

    D. Moussaoui

    
  • ·S01.02 Psychiatry: Subspecialisation and relationship with other disciplines

    Página :214-214

    C. Höschl

    
  • ·S01.03 Tasks and requirements for future clinicians

    Página :214-214

    F. Müller-Spahn

    
  • ·S01.04 Evidence based psychiatry and quality management

    Página :214-214

    W. Gaebel

    
  • ·S01.05 The future focus and clinical impact of research

    Página :215-215

    J. Lopez-Ibor

    
  • ·S01.06 The impact and management of financial restriction'

    Página :215-215

    F.L. Mak

    

• Symposia S02. Epsilson study of schizophrenia

  • ·S02.01 Epsilon study of schizophrenia: Cross-cultural adaptation of outcome measures

    Página :215-215

    H.C. Knudsen, J.L. Vázquez-Barquero, B. Welcher

    
  • ·S02.02 Epsilon study of schizophrenia: Outcome measures, care and service costs

    Página :215-215

    D. Chisholm, G. Thornicroft, M. Knapp, T. Becker

    
  • ·S02.03 Epsilon study of schizophrenia: Satisfaction with psychiatric services

    Página :215-215

    M. Ruggeri, A. Lasalvia, R. Dall'Agnola, G. Bisoffi, M. Tansella

    
  • ·S02.04 Epsilon study of schizophrenia: Evaluation of quality of life in european settings

    Página :216-216

    J.L. Vázquez-Barquero, L. Gaite, C. Borra, M. Pérez Retuerto

    

• Symposia S03. Emergent addictive behaviours

  • ·S03.01 Neural substrates of dependence

    Página :216-216

    L. Pulvirenti

    

• Symposia S03. Emergent addictive behaviour

  • ·S03.02 Perseverative behavior: An emerging concept in psychiatric disorders

    Página :216-216

    B.D. Kretschmer

    
  • ·S03.03 Update in pathological gambling

    Página :216-216

    E. Hollander

    
  • ·S03.04 Is OCD a form of addiction?

    Página :216-216

    J. Zohar

    
  • ·S03.05 Kleptomania and compulsive buying: Clinical features of an italian sample

    Página :216-217

    D. Marazziti, C. Pfanner, S. Presta, L. Dell'Osso, G.B. Cassano

    Resumen Resumen Esquema Esquema

• Symposia S04. Behaviour and motor control in psychiatric disorder

  • ·S04.01 Impulsivity, behavioral dyscontrol, and conscious awareness

    Página :217-217

    E.S. Barratt

    
  • ·S04.02 A new model to assess stimulus processing and behavior control in humans following experimental induction of emotions

    Página :217-217

    M.R. Lemke, T. Wendorff, G. Fritzer, C.J. Fischer, Z. Rupp, S. Tetzlaff

    
  • ·S04.03 Anxiety/aggression-driven depression: A manifestation of serotonergic pathology?

    Página :217-217

    H.M. van Praag

    
  • ·S04.04 Facial expressions and personality

    Página :217-218

    G. Juckel, M. Vogel, A. Präßl, B. Graf, P. Mavrogiorgou, U. Hegerl

    Resumen Resumen Esquema Esquema

• Symposia S04. Behaviour and motor control in psychiatric disorder

  • ·S04.05 Psychomotor retardation in depression during treatment with SSRI's

    Página :218-218

    B.G.C. Sabbe, W. Hulstijn, M. Pier, F.G. Zitman

    

• Symposia S05. The biology and psychology of memory disorder in schizophrenia

  • ·S05.01 Early memory changes in first episode studies

    Página :218-218

    E. Joyce

    
  • ·S05.02 Charcterisation of the memory defects: Access or versus store disorder

    Página :218-218

    T.K. Kondel

    
  • ·S05.03 Probing semantic memory in schizophrenia

    Página :218-218

    A. David

    
  • ·S05.04 Effect of a subanesthetic dose of ketamine on memory and awareness in healthy volunteers

    Página :218-218

    L.A.B. Hetem, J.M. Danion

    
  • ·S05.05 NMDA deficiency as a basis for the cognitive deterioration in schizophrenia

    Página :219-219

    S.R. Hirsch

    
  • ·S05.06 The neuropathology of schizophrenia dementia

    Página :219-219

    M. Davidson

    

• Symposia W13. Negative attitudes and discrimination against severe mentally ill patients

  • ·W13.01 Stigma in schizophrenia: A German point of view

    Página :219-219

    M.C. Angertneyer

    
  • ·W13.02 Stigma and schizophrenia diagnosis: The opinions of Italian psychiatrists

    Página :219-219

    M. Bassi, I. Tarricone

    
  • ·W13.03 Stigma and the concept of schizophrenia in the third millenium

    Página :219-219

    I.F. Brockington

    
  • ·W13.04 The stigma of schizophrenia and ways of diminishing it

    Página :219-219

    P. Byrne

    
  • ·W13.05 Working with patients and their families: The prevention perspective

    Página :219-219

    A. Fioritti, I. Tarricone

    

• Symposia W07. Interpersonal psychotherapy as individual and group treatment on an affective disorder ward

  • ·W07.01 Interpersonal psychotherapy as individual and group treatment on an affective disorder ward

    Página :220-220

    T. Grüttert

    

• Symposia FC01. Family functioning and abuse

  • ·FC01.01 Social factors and women's mental health in Russia

    Página :220-220

    T. Dmitrieva, M. Kachaeva

    
  • ·FC01.02 False allegations of physical abuse in child: Munchausen by proxy or folie a famillle?

    Página :220-220

    I. Savvidou, V. Bozikas, K. Christianopoulos, A. Karavatos

    
  • ·FC01.03 Influence of moclobemide on sexual performance in patients with psychogenic erectile dysfunction

    Página :220-221

    K. Mann, J. Pankok, J. Leissner, O. Benkert

    Resumen Resumen Esquema Esquema

• Symposia FC01. Family functioning and abuse

  • ·FC01.04 Family functioning in the families of patients with bipolar and substance use disorders

    Página :221-221

    C.L. Vandeleur, M. Preisig, F. Ferrero

    
  • ·FC01.05 Incestuous relationships in Czech families

    Página :221-221

    P. Pöthe

    
  • ·FC01.06 Prognostic significance of childhood externalising symptoms

    Página :221-221

    M. Gomez-Beneyto, M. Catali, I. Tomis, Y. Ariza, C. Rubio

    

• Symposia ML01. Main lecture 1

  • ·ML01.01 Putting mental health on the European agenda

    Página :221-221

    J. Eskola

    
  • ·PS01.01 Pharmacological and non-pharmacological approaches in the management of recurrent major depressions

    Página :221-222

    G.A. Fava

    Resumen Resumen Esquema Esquema

• Symposia PS01. Treatment update 2000 — affective disorders

  • ·PS01.02 Pharmacological and non-pharmacological approaches in the management of milder depressions

    Página :222-222

    E.S. Paykel

    
  • ·PS01.03 Pharmacological and non-pharmacological approaches in the long-term management of bipolar disorder

    Página :222-222

    W. Greil, N. Kleindienst

    

• Symposia S06. Evaluation of psychiatric training

  • ·S06.01 Continuing medical (psychiatric) education in Hungary

    Página :222-222

    I. Bitter

    
  • ·S06.02 Evaluation of postgraduate training

    Página :222-222

    I. Tuma

    
  • ·S06.03 Assessment of clinical skills

    Página :223-223

    S.P. Tyrer

    
  • ·S06.04 Examination of psychiatrists in Canada

    Página :223-223

    R. Swinson

    
  • ·S06.05 The future of psychiatric training: What, where, who and how

    Página :223-223

    R. Balon

    

• Symposia S07. Update of genetic research in schizophrenia and affective disorders

  • ·S07.01 Genetic determinants of response to psychopharmacological treatment

    Página :223-223

    M.M. Nöthen

    
  • ·S07.02 Current status of the search for genes contributing to bipolar affective disorder

    Página :223-223

    H. Ewald

    
  • ·S07.03 Current status of the search for genes contributing to schizophrenia

    Página :223-224

    W. Maier, M. Rietschel, D. Lichtermann, D. Müller, T. Schulze, S. Schwab, D. Wildenauer

    Resumen Resumen Esquema Esquema

• Symposia S07. Update of genetic research in schizophrenia and affective disorders

  • ·S07.04 Joint effects of genotype and environment in schizophrenia

    Página :224-224

    P. Tienari

    
  • ·S07.05 Ethical implications of molecular-genetic research in psychiatry

    Página :224-224

    M. Rietschel

    
  • ·S08.01 Is there a neurochemical basis for alcoholism and relapse? Animal and human studies

    Página :224-225

    R.J. Ward

    Resumen Resumen Esquema Esquema

• Symposia S08. Pharmacological relapse prevention in alcoholism — from animal models to clinical trials

  • ·S08.02 Pharmacological behaviour aspects and anticraving” substances — Animal studies

    Página :225-225

    J. Wolffgramm

    
  • ·S08.03 Animal models and clinical trials — How do they fit?

    Página :225-225

    O.M. Lesch

    
  • ·S08.04 Clinical efficacy, possibilities and limitations of acamprosate and naltrexone for treating alcohol dependence

    Página :225-225

    J. Chick

    
  • ·S08.05 Pharmacological treatment trials with dopaminergic and serotonergic substances — Myths or facts?

    Página :225-225

    G. Wiesbeck, H.G. Weijers, J.A.L. Boning

    

• Symposia S09. Day hospital specific treatment protocols

  • ·S09.01 Treatment protocol of suicidal behavior in a day hospital setting

    Página :225-225

    M. Sarchiapone, G. Camardese, V. Carli, E. Barbarino, S. De Risio

    
  • ·S09.02 Day hospital eating disorders unit

    Página :225-226

    A. Ciocca

    Resumen Resumen Esquema Esquema

• Symposia S09. Day hospital specific treatment protocols

  • ·S09.03 Personality disorder treatment

    Página :226-226

    K. Malone

    
  • ·S09.04 A rapid opiate detoxification protocol in D.H. Regimen: Preliminary results

    Página :226-226

    G. Conte, C. Cesaro, D. Catania, S. De Risio

    
  • ·S09.05 Day hospital treatment of mood disorders

    Página :226-226

    M. Sarchiapone, V. Carli, G. Camardese, E. Barbarino, S. De Risio

    

• Symposia S10. Dimensional assessment of personality disorders

  • ·S10.01 The use of behavioral genetic methodology to develop a dimensional measure of personality disorder

    Página :226-226

    K. Jang, J. Livesley

    
  • ·S10.02 The dimensional structure of personality disorder

    Página :226-226

    J. Livesley, K. Jang

    
  • ·S10.03 Personality disorders and the five-factor model of personality — A meta-analysis

    Página :226-227

    F. Ostendorf

    Resumen Resumen Esquema Esquema

• Symposia S10. Dimensional assessment of personality disorders

  • ·S10.04 Dimensional differentiation between anxiety and depression

    Página :227-227

    W. Peñate

    
  • ·S10.05 Universal validity of dimensional personality (disorder) assessment

    Página :227-227

    R. Pulcrop, E.M. Steinmeyer

    

• Symposia W10. Deinstitutionalisation of former long stay patients in Upper-Austria: a case of success?

  • ·W10.01 Liskal — An instrument for evaluation the deinstitutionalisation and planing psychosocial care

    Página :227-227

    A. Grausgruber

    
  • ·W10.02 The deinstitutionalisation in progress: Some critical results

    Página :227-227

    M. Ortmair

    
  • ·W10.03 Living in the community — Problems and success in view of clients and staff

    Página :227-227

    B. Hloch-Wegscheider

    

• Symposia W12. Video-assisted evidence of recent advances in differentiated psychopathology

  • ·W12.01 The development and heuristic value of Leonhard's classification

    Página :227-227

    G.S. Ungvari

    
  • ·W12.02 The nosological differentiation of catatonia

    Página :228-228

    G. Stöber

    
  • ·W12.03 Nosologic differentiation of postpartum psychoses and the role of reproductive functions for the manifestation of endogenous psychoses in women

    Página :228-228

    B. Pfuhlmann, G. Althaus

    
  • ·W12.04 Motility psychosis: A functional disease of the psychomotor sphere

    Página :228-228

    H. Beckmann

    
  • ·W12.05 The nosological differentiation of paranoid schizophrenia

    Página :228-228

    E. Franzek

    

• Symposia FC02. Dementias and organic disorder

  • ·FC02.01 The pathogenetic role of dopamine in HIV-induced CNS disease

    Página :229-229

    E. Koutsilieri, S. Sopper, S. Czub, V. ter Meulen, E. Riederer

    
  • ·FC02.02 Early and differential diagnosis in mild cognitive impairment, Alzheimer's disease and depression

    Página :229-229

    U. Hegerl, T. Frodl, K. Burger, G. Juckel, H. Hampel, R. Engel

    
  • ·FC02.03 Thyroid function of elderly patients with mental disorders

    Página :229-229

    C.A. de Mendonca Lima

    
  • ·FC02.04 Reduction of psychotic symptoms in patients with lewy body-like symptoms treated with olanzapine

    Página :229-230

    W.S. Clark, J. Street, T. Sanger, A. Breier

    Resumen Resumen Esquema Esquema

• Symposia FC02. Dementias and organic disorder

  • ·FC02.05 Association of a cathepsin D gene polymorphism with Alzheimer's disease

    Página :230-230

    A. Papassotiropoulos, M. Bagh, F. Jessen, M. Ludwig, M.L. Rao, W. Maier

    
  • ·FC02.06 Obsessive-compulsive disorder and Huntington's disease in a large Italian pedigree

    Página :230-230

    N. De Marchi, M.G. Ariano, R. Mennella, M.A. Ragone, R. Fusco, A. Dama

    
  • ·DE01.01 Borderline personality disorder is a fiction & irrelevant for treatment

    Página :230-231

    M.H. Stone

    Resumen Resumen Esquema Esquema

• Symposia

  • ·DE01.02 Points concerning the utility of B.P.D.'s relevancy for treatment

    Página :231-231

    H. Sass

    
  • ·PD01.AEP Board of education: Panel discussion on the future of education in Europe

    Página :231-231

    M. Musalek, N. Sartorius

    
  • ·S11.01 From early misconceptions to adult misconceptions

    Página :231-231

    R.M. Murray

    
  • ·S11.02 Transcallosal misconnectivity: The consequence of anomalous lateralization

    Página :231-231

    T.J. Crow

    
  • ·S11.03 The disconnection hypothesis: Theoretical underpinnings

    Página :231-231

    K.J. Friston

    
  • ·S11.04 Using functional neuroimaging to explore connectivity and dysconnectivity in schizophrenia

    Página :231-231

    P. Fletcher

    
  • ·S11.05 Theoretical and methodological considerations for future dysconnectivity research

    Página :232-232

    K. Vogeley

    
  • ·SES02.01 Drug abuse and psychiatric emergencies in developing countries

    Página :232-232

    D. Moussaoui

    
  • ·SES02.02 Crisis interventions in addictions

    Página :232-232

    O.M. Lesch

    
  • ·SES02.03 Emergency drug abuse and security problems: What about treatment?

    Página :232-232

    I. Ferrand

    
  • ·SES02.04 Substance abuse in psychiatric emergencies: The family crisis and its developments

    Página :232-232

    G. Invernizzi

    
  • ·S12.01 Grand rounds: The next generation

    Página :232-232

    R.C. Hsiung

    
  • ·S12.02 Setting up the royal college of psychiatrists' website

    Página :232-233

    D.S. Jago

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S12.03 Internet and psychiatry: A midsummer night's dream?

    Página :233-233

    M. di Giannantonio, F. Calvosa, S. De Risio

    
  • ·S12.04 Ecology, psychiatry, internet and global environment changes

    Página :233-233

    S. Giuseppe, J. Luigi, L.G. Luca

    
  • ·SES03.01 Biological correlates of emotion in borderline personality disorder

    Página :233-233

    C.S. Herpertz, B. Wenning, T. Dietrich, A. Schuerkens, H. Sass

    
  • ·SES03.02 Neurobiological functioning in families with personality disorders and AXIX-I-disorders

    Página :234-234

    W. Maier

    
  • ·SES03.03 How does 5-HT function relate to impulsivity and aggression in highly aggresssive personality disordered male offenders?

    Página :234-234

    M. Dolan, I. Anderson, B. Deakin

    
  • ·SES03.04 Cognitive and neuropsychological investigations in BPD

    Página :234-234

    A. Andreoli, E. Mayer, Y. Burnand, J.M. Annoni, Th. Landis

    
  • ·C05.01 Cognitive psychotherapy

    Página :234-234

    S. Moorey

    
  • ·C01.01 Brief dynamic psychotherapy

    Página :235-235

    A.A. Dahl

    
  • ·FC03.01 Infertile couples — possibility of cognitive-behavioral therapy in reduction distress

    Página :235-235

    J. Djurkovic-Lazic, B. Lazic, D. Djuric

    
  • ·FC03.02 A cognitive-behavioural group-based intervention for social phobia in schizophrenia

    Página :235-235

    S. Halperin, P. Nathan, P. Drummond, D.J. Castle

    
  • ·FC03.03 Interpersonal psychotherapy: Update for 2000

    Página :235-236

    M.M. Weissman, J. Markowitz

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC03.04 The transgenerational psychodynamics of opiate addiction

    Página :236-236

    Zs. Demetrovics

    
  • ·FC03.05 Measuring The ailment”: Perceptions of clinical progress by staff and patients

    Página :236-236

    S.M. Stein

    
  • ·FC03.06 Results of individual psychotherapy of psychosis experienced patients — A 3-years prospective follow-up study

    Página :236-236

    K. Martti

    
  • ·S13.01 The world psychiatric association's consensus statement on the usefulness and use of second generation antipsychotic medications

    Página :236-236

    W.W. Fleischhacker

    
  • ·S13.02 Consensus statements of the world psychiatric association: Rationale, criteria used in selecting topics, utilisation

    Página :237-237

    J. Lopez-Ibor

    
  • ·S13.03 The usefulness and use of second generation antipsychotic medications

    Página :237-237

    N. Sartorius

    
  • ·S13.04 Czech and Slovak meeting on the WPA consensus statement on 2nd generation antipsychotics

    Página :237-237

    J. Libiger

    
  • ·S14.01 Psychotherapy for opiate addicts in methadone substitution — A controlled trial

    Página :237-238

    N. Scherbaum, Th. Finkbeiner, J. Kluwig, D.A. Krause, B. Merget, M. Gastpar

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S14.02 Pharmacokinetics of methadone and Laam, and their clinical relevance

    Página :238-238

    C.B. Eap, P. Baumann

    
  • ·S14.03 Use abuse and dependence from benzodiazepines in methadone maintained patients — Theoretical and pratical issues

    Página :238-238

    G. Forca, E. Levarta, F. Schifano

    
  • ·S14.04 Methadone substitution therapy (MST): Pattern of service configuration across Europe

    Página :238-238

    H. Ghodse, A. Oyefeso

    
  • ·S15.01 State of the art in psychopharmacological therapy of schizophrenia

    Página :238-239

    F. Müller-Spahn

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S15.02 New developments in psychosocial rehabilitation of schizophrenia patients

    Página :239-239

    H.D. Brenner

    
  • ·S15.03 Motivational empowerment — A new approach to cognitive rehabilitation in chronic schizophrenia

    Página :239-239

    M. Kuntze

    
  • ·S15.04 Evaluation of a new methodology of cognitive-emotional social skills training programmes for schizophrenic patients

    Página :239-239

    P. Zorn, V. Roder

    
  • ·S15.05 Virtual reality based assessment and therapy for neuropsychological deficits

    Página :240-240

    A.H. Bullinger

    
  • ·S16.01 Neurobiological basis of craving and pleasure experience: One or more reward systems?

    Página :240-240

    W. Zieglgänsberger

    
  • ·S16.02 Craving for opiates

    Página :240-240

    M. Gossop

    
  • ·S16.03 Craving for alcohol

    Página :240-241

    O.M. Lesch, B. König, K. Ramskogler, A. Riegler, A.G. Zoghlami, H. Walter

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S16.04 Craving for stimulants

    Página :241-241

    L. Janiri

    
  • ·S16.05 Methodological and clinical issues in craving measurement

    Página :241-241

    J. Chick

    
  • ·SES04.01 The concept of hallucinations

    Página :241-241

    P. Berner

    
  • ·SES04.02 Hallucinations as disorders of intersubjectivity

    Página :241-241

    G. Stanghellini

    
  • ·SES04.03 Auditory hallucinations: Mapping the neural network using functional magnetic resonance imaging

    Página :242-242

    S.S. Shergill, M.J. Brammer, S.C.R. Williams, R.M. Murray, P.K. McGuire

    
  • ·SES04.04 Auditory hallucinations and hearing impairment

    Página :242-242

    M. Musalek, B. Hobel, A. Zpghlami, N. Benda, R. Eher, G. Fruhwirt, H. Krudl, A. Neumeister, J. Stössl, S. Zadro-Jaeger

    
  • ·SES04.05 Treatment and outcome in hallucinatory states

    Página :242-242

    S. Opjordsmoen, N. Retterstöl

    
  • ·SES05.01 Operating a secure unit is cooperating

    Página :242-242

    H. van Marle

    
  • ·SES05.02 Forensic security measures in Switzerland: From law to institutions

    Página :242-243

    G. Niveau

    Resumen Resumen Esquema Esquema

• Symposia

  • ·SES05.03 Psychotherapy process research in therapies with sex offenders in forensic secure units

    Página :243-243

    F. Präfflin

    
  • ·SES05.04 Forensic care in Sweden

    Página :243-243

    F. Hagelbäck-Hansson

    
  • ·FC04.01 Responsiveness of central serotonin receptors in panic disorder: Effects of clomipramine treatment and exercise

    Página :243-243

    A. Broocks, E. Rüther, U. Munzel, G. Hajak, D. Wedekind, B. Bandelow

    
  • ·FC04.02 Deep brain stimulation for severe refractory obsessive-compulsive disorder: A new last-resort therapeutic option?

    Página :243-243

    L. Gabriëls, P. Cosyns, B. Nuttin

    
  • ·FC04.03 Medical utilization and costs in panic disorder

    Página :243-244

    G. Megale, A. Lo Balbo, C. Collazo

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC04.04 Pregabalin treatment of generalised anxiety disorder (GAD); three randomised, placebo controlled trials

    Página :244-244

    A.C. Pande, J.G. Crockatt, C. Janney, D.E. Feltner

    
  • ·FC04.05 Personality dimensions and current psychological symptoms nine months after a stressful event (air attacks)

    Página :244-244

    D. Lecic-Tosevski, S. Priebe, J. Gavrilovic, M. Pejovic-Milovancevic, G. Knezevic

    
  • ·FC04.06 Relationship between stressful life experiences and current symptoms after air attacks

    Página :244-244

    J. Gavrilovic, S. Priebe, D. Lecic-Tosevski, M. Pejovic-Milovancevic, G. Knezevic

    
  • ·SAT01.01 Treatment of psychiatric illness: Psychotherapy, pharmacotherapy, anything else?

    Página :245-245

    N. Sartorius

    
  • ·SAT01.02 Pharmacotherapy and psychotherapy: State of the science

    Página :245-245

    M. Lader

    
  • ·SAT01.03 Pharmacotherapy and psychotherapy: State of the art

    Página :245-245

    F. Lelord

    
  • ·SAT01.04 Pharmacotherapy with which psychotherapy?: Results of the espace study

    Página :245-245

    F. Rouillon

    
  • ·S17.01 Functional neuroimaging of cognition: A challenge to neuropsychology

    Página :246-246

    M. Gaviria, D. Medina, Y. Sosa

    
  • ·S17.02 Structural findings in neuropsychiatric disorders: The role of stress

    Página :246-246

    C. Arango, E. Olivares, R. Buchanan

    
  • ·S17.03 Functional imaging in neurodevelopmental disorders

    Página :246-246

    P. Sandor, J. Silveira, D. Mikulis, A. Crawley

    
  • ·S17.04 Insular cortex abnormalities in schizophrenia: Clinical correlates and significance

    Página :246-246

    B. Crespo-Facorro

    
  • ·S18.01 Involuntary, compulsory or coerced treatment: New trends in Belgium

    Página :246-247

    P. Cosyns

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S18.02 Human rights and compulsive treatment

    Página :247-247

    M. Kastrup

    
  • ·S18.03 Psychiatry and human rights in Romania. Involuntary commitment. 30 years experience

    Página :247-247

    N. Tataru

    
  • ·S18.04 Involuntary commitment in Germany — Ethics, law and practice

    Página :247-247

    N. Nedopil

    
  • ·S18.05 Unvoluntary commitment in France: A model or an exception?

    Página :247-247

    B. Lachaux

    
  • ·SES06.01 Antecedents and early course of affective psychosis

    Página :248-248

    H. Verdoux

    
  • ·SES06.02 Prodromi and early course of schizophrenia and its consequences

    Página :248-248

    W. Löffler, H. Häfner

    
  • ·SES06.03 Predicting the risk of psychosis

    Página :248-248

    K. Maurer

    
  • ·IS01.01 Suicide in adolescents

    Página :248-248

    C. van Heeringen

    
  • ·IS01.02 Suicide in women

    Página :248-249

    I. Brockington

    Resumen Resumen Esquema Esquema

• Symposia

  • ·IS01.03 Suicide in men

    Página :249-249

    J. Wålinder, W. Rutz, Z. Rihmer, P. Pestality

    
  • ·IS01.04 Suicide in the elderly

    Página :249-249

    E.D. Caine

    
  • ·S19.01 Psychotherapy and cellular function

    Página :249-249

    J. Aldenhoff

    
  • ·S19.02 Psychotherapy and neuroimaging: Effect of cognitive and behavioural therapy on orbito-frontal-subcortical circuits in obsessive-compulsive disorder

    Página :249-249

    F. Hohagen

    
  • ·S19.03 Spet studies on outcome of treatment by psychosocial interventions in depression and hysterical paresthesia

    Página :249-249

    J. Lehtonen, J. Kuikka, H. Viinamäki, J. Tiihonen, M. Husso-Saastamoinen

    
  • ·S19.04 Psychopharmacology and psychotherapy affect the same brain structures

    Página :250-250

    F.A. Henn, E. Edwards

    
  • ·S20.01 Sexual disorders: Diagnostic and epidemiological issues

    Página :250-250

    R.T. Segraves

    
  • ·S20.02 Sexual dysfunction and psychopathology in the elderly

    Página :250-250

    D. Aizenberg

    
  • ·S20.03 Psychological aspects of sexual disorders

    Página :250-251

    K. Segraves

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S20.04 Biological treatments of paraphilias and premature ejaculation

    Página :251-251

    R. Balon

    
  • ·S20.05 Treatment of sexual dysfunction associated with medication

    Página :251-251

    Z. Zemishlany

    
  • ·S21.01 Cognitive rehabilitation in psychiatric patients

    Página :251-252

    H.D. Brenner

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S21.02 Cognitive dysfunctions in psychotic patients: Relationship with symptoms and antipsychotic treatment

    Página :252-252

    S. Galderisi, A. Mucci, M. Maj

    
  • ·S21.03 Hemispheric asymmetries and psychotism

    Página :252-252

    J. Gruzelier

    
  • ·S21.04 A neurophysiological framework for psychosis

    Página :252-252

    M. Koukkou

    
  • ·W03.01 Problems of the undergraduate training in psychiatry in the Czech Republic

    Página :252-253

    J. Libiger, I. Tuma

    Resumen Resumen Esquema Esquema

• Symposia

  • ·W03.02 Undergraduate studies in psychiatry in the problem-based learning medical curriculum at university of tampere

    Página :253-253

    R. Kaltiala-Heino, A. Pasternack

    
  • ·W03.03 Education in liaison psychiatry

    Página :253-253

    M. Musalek, B. Hobl, U. Mossbacher, A. Zoghlami

    
  • ·W03.04 Education & training in psychiatry in Europe: Undergraduate teaching and training in Turkey

    Página :253-254

    V. Sar

    Resumen Resumen Esquema Esquema

• Symposia

  • ·W03.05 Toward better public mental health by means of problem oriented and community based mental health education

    Página :254-254

    M.W. deVries

    
  • ·W03.06 Psychiatric education and the changing undergraduate curriculum in the UK

    Página :254-254

    M. Greenberg

    
  • ·FC05.01 The association between one-year outcome of major depression and care utilisation in the general population. Findings from The Netherlands mental health survey and incidence study (Nemesis)

    Página :254-254

    J. Spijker, R.V. Bijl, R. de Graaf, W.A. Nolen

    
  • ·FC05.02 Psychopathology and treatment prognosis in BDV-infected patients

    Página :254-255

    C.W. Spannhuth, D.E. Dietrich, L. Bode, T. Lau, T.J. Huber, H. Ludwig, H.M. Emrich

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC05.03 Familial relationship between bipolar I disorder and attention-deficit/hyperactivity disorder

    Página :255-255

    M. Preisig, F. Ferrero

    
  • ·FC05.04 Influence of pharmacologically different antidepressants on neurocognition of patients with depressive disorders

    Página :255-255

    N.-U. Neumann, St. Bretschneider, Ch. Bullacher, K. Frasch, R. Hess, R. Wittek

    
  • ·FC05.05 A genome-wide scan in 10 multiplex families with bipolar disorder

    Página :255-255

    S.J. Claes, A. Patterson, J. Del-Favero, S. Van Gestel, J. Mendlewicz, F. Macciardi

    
  • ·FC05.06 Harm avoidance and 5-HT2A receptors in depression

    Página :256-256

    H.A.H. D'haenen, A. Van Mol, C. Vanhove, J. Mertens, K. Chavatte, D. Terriere

    
  • ·ML02.01 Growing together in diversity

    Página :256-256

    N. Sartorius

    
  • ·PS02.01 Social phobia

    Página :256-256

    Y. Lecrubier

    
  • ·PS02.02 Panic disorder

    Página :256-256

    A.A. Dahl

    
  • ·PS02.03 Somatization disorder

    Página :256-256

    S. Wessely

    
  • ·PS02.04 Post-traumatic stress disorder

    Página :256-256

    L. Weisæth

    
  • ·S22.01 Psychotherapy in psychiatry

    Página :256-256

    K.C. Treichel

    
  • ·S22.02 Global priorities in psychiatry

    Página :256-256

    J.L. Ayoso

    
  • ·S22.03 The rise of biological psychiatry

    Página :256-256

    M. Eronen

    
  • ·S22.04 Deinstitutionalisation

    Página :257-257

    P. Munk-Jørgensen

    
  • ·S22.05 Psychiatry in Eastern Europe

    Página :257-257

    X. Solozhenkina

    
  • ·SES07.01 How to manage early intervention

    Página :257-257

    J. Klosterkötter

    
  • ·SES07.02 Cognitive treatment in early psychotic breakdown

    Página :257-257

    P.A. Garety

    
  • ·SES07.03 Early detection and intervention in psychosis, the stavanger model

    Página :257-257

    J.O. Johannessen

    
  • ·SES08.01 Quality of life — a new concept and its measurement

    Página :257-257

    H. Katschnig

    
  • ·SES08.02 The SF-36 in an observational study of alcohol dependent patients treated with acamprosate

    Página :257-257

    P. Lehert, F. Landron

    
  • ·SES08.03 Application of quality of life measures to alcohol misusers

    Página :258-258

    T.J. Peters, J. Foster

    
  • ·SES08.04 Quality of life in institutionalized alcoholics with psychiatric comorbidity

    Página :258-258

    M. Berglund, B. Sallmén, B. Bokander

    
  • ·SES08.05 Quality of life, drinking and smoking in alcoholics 7 years after treatment

    Página :258-258

    K. Mann, K. Ackermann

    
  • ·S23.01 Changes in gene expression during TMS

    Página :258-258

    T.E. Schlaepfer

    
  • ·S23.02 Revealing abnormalities in cortical excitability in depressive disorders with TMS

    Página :258-258

    F. Maeda

    
  • ·S23.03 Functional neuroimaging during TMS

    Página :258-258

    K.P. Ebmeier

    
  • ·S23.04 Monitoring TMS with EEG and MEG

    Página :259-259

    R. Ilmoniemi

    
  • ·S23.05 Do changes in cortical output maps correlate with clinical response during TMS in patients with MDD?

    Página :259-259

    L. Grunhaus

    
  • ·SES09.01 Violence as a public health issue. The contribution of psychiatrists to an integrated multidimensional approach

    Página :259-259

    A. Andreoli

    
  • ·SES09.02 When violence is a psychiatric disorder

    Página :259-259

    M. Furlan

    
  • ·SES09.03 Violence in psychiatric institutions in developing countries

    Página :259-259

    D. Moussaoui

    
  • ·W01.01 Attitudes of the general population concerning schizophrenia

    Página :259-259

    A. Grausgruber

    
  • ·W01.02 Attitude starts in school. A programme in approach to reduce stigma in schools

    Página :259-259

    U. Meise

    
  • ·W01.03 Why is it important for Austria to establish an anti-stigma-programme on schizophrenia?

    Página :259-259

    W.W. Fleischhacker

    
  • ·W01.04 Activities of fighting stigma: An example of a regional campaign

    Página :259-260

    W. Schöny

    Resumen Resumen Esquema Esquema

• Symposia

  • ·W14.01 The epidemiology of suicide

    Página :260-260

    E. Szadoczky

    
  • ·W14.02 Biological factors in suicide

    Página :260-260

    C.M. Bánki

    
  • ·W14.03 Social factors and psychotherapy in suicide

    Página :260-260

    F. Füredi

    
  • ·W14.04 Pharmacological treatment and prevention in suicide

    Página :260-260

    Z. Rihmer

    
  • ·W14.05 Suicide in slovenia from 1970 to 1997

    Página :260-260

    S. Ziherl, B. Zalar

    
  • ·FC06.01 Regulation of serotonin transporter trafficking by treatment in human platelets

    Página :260-260

    K.Y. Little, L. Zhang, A. Shakoor

    
  • ·FC06.02 First results of fluvoxamine versus lithium aggressivity protocol (FLAP)

    Página :261-261

    G. La Malfa, M. Bertilli, M. Conte, P. Cabras

    
  • ·FC06.03 Association of serotonin transporter promoter gene variants with clinical features of major depression

    Página :261-261

    A. Putzhammer, P. Eichhammer, T. Rohrmeier, H. Sartor, L. Angermueller, P. Dallinger, U. Frick, H.E. Klein, A. Schoeler

    
  • ·FC06.04 Spect imaging of 5-HT_2A receptors during SSRI treatment

    Página :261-261

    H. D'haenen, P. Lezaire, C. Vanhove, J. Mertens, K. Chavatte, D. Terriere, A. Bossuyt

    
  • ·FC06.05 Multiparametric biomonitoring of autonomic functions in patients treated with psychotropic drugs

    Página :261-262

    M. Mueck-Weymann, J. Acker, T. Rechlin, R. Rauh, P. Joraschky

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC06.06 Decreased serotonin 5-HT2A binding potential in patients with anorexia nervosa

    Página :262-262

    K. Titeca, K. Audenaert, K. Van Laere, F. Dumont, M. Vervaet, G. Slegers

    
  • ·DE02.01 Has dynamic psychiatry a future?

    Página :262-262

    A.A. Dahl, D. Goldberg

    
  • ·SES10.01 Epidemiology of dementia and cognitive impairment: recent developments

    Página :262-262

    C. Brayne

    
  • ·SES10.02 Eurocare: A cross-national study of co-resident spouse carers for people with Alzheimer's disease

    Página :262-263

    J. Murray, S. Banerjee, J. Schneider, A. Mann

    Resumen Resumen Esquema Esquema

• Symposia

  • ·SES10.03 Special care units for demented patients

    Página :263-263

    G.B. Frisoni

    
  • ·SES10.04 The burden of care among nurses in homes for the elderly

    Página :263-263

    S. Weyerer

    
  • ·S24.01 Are the dermatoglyphic findings in schizophrenia specific markers of the disorder? Results from a sample of mentally healthy adult survivors of very low birthweight

    Página :263-263

    P. Fearon, L. Fañanás, M. Taylor, L. Rifkin, R. Murray

    
  • ·S24.02 Is there recognisable neurocognitive profile associated with dermatoglyphic anomalies in psychosis?

    Página :263-264

    A. Rosa, F. Serrano, A. Zarzuela, A. Martinez-Larrea, M. Cuesta, V. Peralta, L. Fañanás

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S24.03 Can the dermatoglyphic evidence be validated by MRI images?

    Página :264-264

    J. van Os

    
  • ·S24.04 Associations between dysmorphic features, dermatoglyphics and lateralisation in psychosis

    Página :264-264

    A. Lane, J. Reilly, O. McTigue, P. Fearon, M. Byrne, C. Larkin, E. O'Callaghan

    
  • ·S24.05 Association between cerebral structural abnormalities and dermatoglyphic ridge counts in schizophrenia

    Página :264-264

    J. van Os, P. Woodruff, L. Fañanas, F. Ahmad, N. Shuriquie, R. Howard, R.M. Murray

    
  • ·S25.01 The epsilon study of schizophrenia in five European countries

    Página :264-264

    T. Becker, M. Knapp, H.C. Knudsen, A. Schene, M. Tansella, G. Thornicroft, J.L. Vazquez-Barquero

    
  • ·S25.02 The prevention of crime and violence among the mentally ill

    Página :264-265

    S. Hodgins

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S25.03 The behavioural psychopathology of blood disorders. A cross-national study

    Página :265-265

    I. Kolvin, H. Sadowski, C. Clemente, B. Taylor, C.A. Lee, J. Tsiantis, S. Baharaki, M. Mannuci, G. Ba

    
  • ·S25.04 The euro-MDSBL project: Developing common standards for the assessment of disablement in mental and neurological patients in six European countries

    Página :265-265

    V. Mavreas, C. Pull, R. Jenkins, H.W. Hoek, C. Caltagirone, J.L. Vasquez-Barquero, T.B. Ustun

    
  • ·S26.01 The interrelationship between amino acids and β-carbolines

    Página :265-266

    D. Fekkes, L. Pepplinkhuizen

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S26.02 Acute polymorphous psychosis due to endogenic synthesis of β-carbolines

    Página :266-266

    L. Pepplinkhuizen, D. Fekkes

    
  • ·S26.03 The hallucinations-inducing effect of β-carbolines

    Página :266-266

    H. Rommelspacher, C. Spies, J. Dierkes

    
  • ·S26.04 Amino acids and norharman in depression and panic disorder

    Página :266-266

    L. Timmerman, D. Fekkes, L. Pepplinkhuizen

    
  • ·S26.05 Norharman in mentally retarded patients

    Página :267-267

    S. Tuinier, W.M.A. Verhoeven, L. Pepplinkhuizen, D. Fekkes

    
  • ·S27.01 Longterm course of bipolar disorder

    Página :267-267

    J. Angst, F. Angst, R. Sellaro, H. Zhang

    
  • ·S27.02 Persistent dysregulations in pure BP-1 disorder versus mixed states

    Página :267-267

    G. Perugi

    
  • ·S27.03 Polarity congruency between affective temperaments and major episodes in mood disorders

    Página :267-267

    E.-G. Hantouche

    
  • ·S27.04 Prospective assessment of affective temperaments in a cohort of juvenile depressives

    Página :268-268

    F.J. Kochman, E.G. Hantouche, J.A. Meynard, G. Hamm, D. Bayart

    
  • ·S27.05 Temperamental dysregulations in mood disorders

    Página :268-268

    H.S. Akiskal

    
  • ·C04.01 Psychiatrists and the media

    Página :268-268

    O. Cuenca, A.W. Clare

    
  • ·C03.01 Human brain imaging course

    Página :268-269

    G. Sedvall

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC07.01 Novelry seeking and harm avoidance dimensions in the prediction of suicide attempt behavior among psychiatric patients

    Página :269-269

    S. Gil

    
  • ·FC07.02 The experience of patient suicide among trainees in psychiatry

    Página :269-269

    K.P. Courtenay, J.P. Stephens

    
  • ·FC07.03 Suicide behavior in Russia in 1980–1990S: Indices and factors

    Página :269-269

    V. Krasnov, V. Voitsekh, A. Nemtsov

    
  • ·FC07.04 Borderline personality disorder and suicide

    Página :269-269

    J.J. McCutchan, O. Junker

    
  • ·FC07.05 Attitudes of medical students towards suicide

    Página :270-270

    O. Kulśková, T. Urbánek

    
  • ·FC07.06 A case control study of suicide amongst persons not involved with mental health services

    Página :270-270

    K.R. Lloyd, N.J. Booth, C.V. Owens

    
  • ·S28.01 Changes in ABETA4 plasma levels and other markers: Results from a comprehensive multicenter study of peripheral bilogical and neuropsychological variables in early Alzheimer's disease

    Página :270-270

    P.J. Rogue

    
  • ·S28.02 Clinicaopathological correlations and the differential diagnosis of dementias

    Página :270-270

    C. Derouesne

    
  • ·S28.03 Neuroimaging in Alzheimer's disease

    Página :270-270

    J. de Groot

    
  • ·S28.04 Biochemical markers and the diagnosis of Alzheimer's disease — Overview

    Página :270-270

    M. Novak

    
  • ·S28.05 Increased CSF levels of a presenilin I loop fragment in sporadic Alzheimer's disease: Possible biological marker

    Página :270-270

    R. Nitsch

    
  • ·ISO2.01 Fighting stigmatisation because of schizophrenia in spain: results

    Página :271-271

    J.J. Lopez-Ibor

    
  • ·ISO2.02 Fighting stigma and discrimination because of schizophrenia

    Página :271-271

    N. Sartórius

    
  • ·ISO2.03 Combining a programme against stigma with a comprehensive research programme on schizophrenia

    Página :271-271

    W. Gaebel

    
  • ·IS02.04 The Austrian programme on fighting stigma because of schizophrenia

    Página :271-271

    W. Schöny

    
  • ·IS02.05 Anti-stigmatisation programme in ITALY

    Página :271-272

    G. ossi

    Resumen Resumen Esquema Esquema

• Symposia

  • ·IS02.06 Anti-stigmatisation programme in GREECE

    Página :272-272

    C.N. Stefanis, M. conomou

    
  • ·S29.01 Biomed-merope project for adults with psychiatric disorders and mental retardation

    Página :272-272

    N. Bouras, G. Holt, J. Hillery, L. Salvador, J. Tsiantis, G. eber

    
  • ·S29.02 A European technology for comparing mental health care systems. Adaptation, validation and application in a large sample of Italian catchment areas

    Página :272-272

    G. Tibaldi, C. Munizza, E. Scala, C. Palazzi, M. Zuccolin, S. Cesano, G. Fantini, R. Dazzi, C. Testa

    
  • ·S29.03 The family of the schizophrenic patient: Objective and subjective burden and coping strategies

    Página :273-273

    L. Maglianol, G. Fadden, J.M. Caldas de Almeida, M. Madianos, T. Held, M. Maj

    
  • ·S30.02 Behavioural pharmacology of MDMA in nonhumans

    Página :273-273

    C.-E. Johanson

    
  • ·S30.02 Effects of MDMA (ecstasy) on sensorimotor gating (prepulse inhibition) in humans after pretreatment with citalopram, haloperidol, or ketanserin

    Página :273-273

    F.X. Vollenweider, M.E. Liechti, M. Geyer, D. Hell

    
  • ·S30.03 Subjective and reinforcing effects of MDMA and mCPP compared to d-amphetamine in humans

    Página :273-273

    M. Tancer, C.-E. Johanson

    
  • ·S30.04 Functional brain imaging after acute and chronic exposure to MDMA (ecstasy”)

    Página :273-273

    A. Gamma, A. Buck, T. Berthold, M.E. Liechti, F.X. Vollenweider

    
  • ·SES11.01 Causality of personality disorders and therapeutic intervention: A review of the psychoanalytic literature, 1908–1990

    Página :273-273

    F. Sauvagnat

    
  • ·SES11.02 Emerging from borderline state of mind: Psychoanalytic view

    Página :273-273

    M. Sebek

    
  • ·SES11.03 Repairing the trauma: The internalization of the analytic relationship by the borderline patient

    Página :273-274

    Z. Christos

    Resumen Resumen Esquema Esquema

• Symposia

  • ·SES11.04 Psychotherapy of suicidal patients

    Página :274-274

    D. Cremniter

    
  • ·SES11.05 Sojourn in the psyche: some effects of (borderline patients') projective identifications

    Página :274-274

    G. Vaslamatzis

    
  • ·FC08.01 Personality disorders and early development in female offenders

    Página :274-274

    M. Kachaeva, T. Dmitrieva

    
  • ·FC08.02 Ethnocultural peculiarities of suicide prevalence in RUSSIA

    Página :274-275

    B. olozhy

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC08.03 Peculiarities of socially dangerous behavior of the mentally ill in modern Russia

    Página :275-275

    T. Dmitrijeva, Z. olozhaya

    
  • ·FC08.04 Impact of depression, impulsivity and recent life-events in first-time and repeat suicide attempts

    Página :275-275

    M. Benoit, M. Jaubert, F. Askenazy, P.H. Robert, D. Pringuey, G. arcourt

    
  • ·FC08.05 ADHD as a risk factor for sexual delinquency

    Página :275-275

    D. Blocher

    
  • ·FC08.06 Mentally disordered offenders in Britain: Current practice and future proposals

    Página :275-275

    C.S.H. Brown

    
  • ·SES12.01 Women and organised violence

    Página :276-276

    M. Kastrup

    
  • ·SES12.02 Genetics of puerperal psychosis

    Página :276-276

    I. Jones

    
  • ·SES12.03 Danish national studies of postpartum mental illness

    Página :276-276

    I.M. Terp, P.B. Mortensen, G. Engholm, H. Møller

    
  • ·SES12.04 Psychiatry of the menopause

    Página :276-276

    G. olnar

    
  • ·SES12.05 Psychiatry of female criminality

    Página :276-276

    T. Dmitrieva

    
  • ·SES12.06 Obstetric liaison services

    Página :276-276

    A. Rohde

    
  • ·S31.01 History and current development in CZECH psychiatry

    Página :276-277

    J. Raboch

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S31.02 The pros and cons of a czech education: Experience of a Norwegian psychiatrist Experience of a Norweigian psychiatrist

    Página :277-277

    A. Restan

    
  • ·S31.03 The history of czech psychopharmacology and psychopharmacotherapy of affective and schizophrenic disorders

    Página :277-277

    J. Svestka

    
  • ·S31.04 Search for genes for bipolar disorder: The Czech-Canadian connection Cze-Canadian connection

    Página :277-277

    M. Alda, P. Zvolský, P. Grof

    
  • ·S32.01 New antipsychotics: Symptoms and clinical course

    Página :277-278

    W. Gaebel

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S32.02 Quality of life and new antipsychotic medications in schizophrenia

    Página :278-278

    A.G. Awad

    
  • ·S32.03 New antipsychotics: The issue of side-effects

    Página :278-278

    W.W. Fleischhacker

    
  • ·S32.04 Pharmacotherapy and the interaction with psychosocial treatment psychosocial treatment

    Página :278-278

    W. Rössler

    
  • ·S32.05 Economics of new antipsychotics

    Página :278-278

    M. Knapp

    
  • ·S33.01 Genetics of suicidal behaviour

    Página :278-278

    W. Maier

    
  • ·S33.02 Biological markers for suicidal behaviours in alcoholics

    Página :278-278

    P. Gorwood

    
  • ·S33.03 The biology of suicide: the dimensional versus the diagnostic correlates

    Página :278-279

    J.J. Mann

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S33.04 Suicide and young people

    Página :279-279

    B.S. Runeson

    
  • ·S34.01 Midazoline receptors: Potential markers for depression and targets of antidepressant drug development

    Página :279-279

    A. Halaris, J.E. Piletz

    
  • ·S34.02 Cloning of a candidate imidazoline receptor CDNA from human hippocampus

    Página :279-279

    J.E. Piletz, M. Chen, M.E. Lutrick, H. Zhu, J. Baldwin

    
  • ·S34.03 Brain and platelet imidazoline receptors in mood disorders

    Página :279-280

    J.A. Garcia-Sevilla, P.V. Escribá, J. Guimón

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S34.04 Imaging noradrenergic and non-adrenergic binding of [³H]clonidine in brains from psychiatrically characterized humans

    Página :280-280

    G.A. Ordway, G. Rajkowska, H. Zhu, B.J. Duncan, C.A. Stockmeier, G. Dilley, L. Konick, H.Y. Meltzer, J.C. Overholser, J.E. Piletz, A. Halaris

    
  • ·S34.05 New approaches to imidazoline receptors

    Página :280-280

    D.J. Nutt, R. Price, R. Tyacke, S. Husbands, J. Lewis, D. Finn, M. Lalies, A.L. Hudson

    
  • ·S35.01 Somatoform disorders and concurrent concepts in internal medicine

    Página :280-280

    N. Sartorius, A. Janca

    
  • ·S35.02 Genetic basis of somatoform disorders

    Página :281-281

    W. Maier

    
  • ·S35.03 Chronic fatigue syndrome: Is it a virus or not?

    Página :281-281

    S. Wessely

    
  • ·S35.04 Genetics and pathophysiology of the fibromyalgia syndrome

    Página :281-281

    M. Ackenheil, M.J. Schwarz, B. Bondy, M. Offenbaecher, M. Späth

    
  • ·W04.01 Informed consent, ethical questions

    Página :281-281

    L. Jacobsson

    
  • ·W04.02 Ethical problems with a health database legislation

    Página :282-282

    T. Helgason

    
  • ·W04.03 Ethical review of psychiatric research protocols

    Página :282-282

    M. Lader

    
  • ·W04.04 Ethical questions in genetic psychiatric studies

    Página :282-282

    W. Maier

    
  • ·W04.05 Ethics of psychiatric postmortem brain research

    Página :282-282

    D. Radu, G. Sedvall

    
  • ·W11.01 Clinical application of hypnotherapy

    Página :282-282

    V.M. Mathew

    
  • ·W11.02 Various hypnotic techniques

    Página :282-282

    M. Joseph

    
  • ·W11.03 Practical demonstration and group induction

    Página :283-283

    U. James

    
  • ·W11.04 Structure and functions of British hypnotherapy examinations board

    Página :283-283

    L. Mathew

    
  • ·FC09.01 Binocular rivalry is slow in bipolar disorder but not in schizophrenia or major depression

    Página :283-283

    S.M. Miller, G.B. Liu, T.T. Ngo, L.B. Geffen, B.D. Gynther, P.B. Mitchell, J.D. Pettigrew

    
  • ·FC09.02 The Calgary depression rating scale for schizophrenia (CDSS): Reliability and validity data of a German version

    Página :283-283

    M.J. Müller, O. Benkert

    
  • ·FC09.03 Estabilishing onset in first episode psychosis: The Nottingham onset schedule (NOS)

    Página :283-284

    S.P. Singh, J.E. Cooper, C.J. Tarrant, H. Bagalkote, P.B. Jones

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC09.04 The prodrome of first onset psychoses: Are affective symptoms specific to diagnosis?

    Página :284-284

    C.J. Tarrant, S.P. Singh, J.E. Cooper, T. Lloyd, P.B. Jones

    
  • ·FC09.05 Clozapine, olanzapine, risperidone, and haloperidol in refractory schizophrenia

    Página :284-284

    P. Mohr, J. Volavka, J.A. Lieberman, P. Czobor, J. McEvoy, J.-P. Lindenmayer, L. Citrome, B. Sheitman

    
  • ·FC09.06 Cholecystokinin CCK_b receptor mRNA Isoforms: Expression in postmortem monkey and human brain - alterations following schizophrenia

    Página :284-285

    N.L.D. Radu, O. Zachrisson, J. de Belleroche, K.R. Wendt, S. Hirsh

    Resumen Resumen Esquema Esquema

• Symposia

  • ·ML03.01 Malignant sadness - The evolutionary psychology of depression

    Página :285-285

    L. Wolpert

    
  • ·PS03.01 Treatment of alzheimer's disease

    Página :285-285

    J.T. O'Brien

    
  • ·PS03.02 Treatment of behavioural symptoms in dementia

    Página :285-285

    H. Förstl

    
  • ·PS03.03 Treatment of the dementia disease process

    Página :285-285

    S. Lovestone

    
  • ·SES13.01 Possibilities and limitations in unification of of standards - the challenge in child and adolescent psychiatry

    Página :285-285

    M. Dabkowski

    
  • ·SES13.02 Outcome of childhood separation anxiety disorder

    Página :285-285

    D. Bailly

    
  • ·SES13.03 Grief work and adolescent development

    Página :285-285

    A. Barbosa

    
  • ·SES13.04 Quality of attachment in adolescents hospitalized in crisis unit hospitalized in crisis unit

    Página :285-285

    V. Delvenne

    
  • ·SES13.05 The trauma of separation for anorexic patients: An etiopathogenic agent and a support for treatment

    Página :285-285

    J.L. Venisse

    
  • ·S36.01 A comparison of the utility of dimensional and categorical representations of psychosis

    Página :286-286

    J. van Os, C. Gilvarry, R. Bale, E. van Horn, T. Tartan, I. White, R. urray

    
  • ·S36.02 Psychosis is better described as a continuum, rather than as categories

    Página :286-286

    P.K. McGuire, T.A. Dixon

    
  • ·S36.03 Delusions in the general population

    Página :286-286

    H. Verdoux, J. van Os, S. Maurice-Tison, B. Gay, R. Salamon

    
  • ·S36.04 First rank symptoms in schizophrenia: No basis in evidence

    Página :287-287

    V. Peralta, M.J. Cuesta

    
  • ·S36.05 Are schizophrenics cognitively impaired manics?

    Página :287-287

    R.M. Murray

    
  • ·S37.01 Psychological autopsy studies

    Página :287-287

    E.T. Isometsä

    
  • ·S37.02 The influence of comorbidity on the prevalence of suicidal behaviour

    Página :287-287

    Y. Lecrubier

    
  • ·S37.03 Suicide attempts in placebo controlled trials

    Página :287-287

    T. Laughren

    
  • ·S37.04 The efficacy of psychosocial and pharmacological treatment following deliberate self-harm: a systematic review

    Página :287-288

    K. Hawton

    Resumen Resumen Esquema Esquema

• Symposia

  • ·SES14.01 From receptor pharmacology to clinical prescription: antidepressants

    Página :288-288

    F. Bengtsson

    
  • ·SES14.02 From receptor pharmacology to clinical prescription: antipsychotics

    Página :288-288

    J. ibert-Rahola

    
  • ·SES14.03 Practical problems with co-prescription: Problems with efficacy

    Página :288-289

    M. Ackenheil

    Resumen Resumen Esquema Esquema

• Symposia

  • ·SES14.04 Practical problems with co-prescription: Problems with side effects

    Página :289-289

    L.K.M. Jaime, M. Ackenheil

    
  • ·SES14.05 Transnosological prescription

    Página :289-289

    D. Marazziti

    
  • ·W06.01 Concept, structure, and function of the German research network on schizophrenia

    Página :289-289

    W. Wölwer, W. Gaebel

    
  • ·W06.02 Early detection and intervention in populations at risk

    Página :289-289

    H. Häfner, J. Klosterkötter

    
  • ·W06.03 New pharmacological treatment strategies: Acute first episode schizophrenia, non-response and predominant negative symptoms

    Página :289-289

    H.J. Möller

    
  • ·W06.04 Long-term treatment of first episode schizophrenia: New strategies, prodromal symptoms and biological basis of relapse

    Página :290-290

    W. Gaebel

    
  • ·W06.05 New strategies in prevention and rehabilitation of residual schizophrenia

    Página :290-290

    S. Klingberg, O. Buchkremer

    
  • ·W06.06 Molecular-genetic predictors of illness manifestation, course, and treatment response

    Página :290-290

    W. Maier, M. Ackenheil, M. Rietschel, T. Bayer

    
  • ·W08.01 An educational program for the prevention of drug abuse in a high - school

    Página :290-290

    E. Koumbi

    
  • ·W08.02 Early prevention of drug abuse: Methodological and conceptual considerations

    Página :290-290

    E. Tempesta

    
  • ·W08.03 The planning and implementation of primary prevention programmes in schools. Evidence based reconsideration

    Página :290-290

    C. Kröger

    
  • ·W08.04 Methodological and ethical limitations of school based addiction prevention

    Página :291-291

    R. Müller

    
  • ·FC10.01 Outcome of patients with severe mental illness and borderline intellectual functioning

    Página :291-291

    A. Hassiotis, O. Ukoumunne, S. Byford, P. Tyrer, K. Harvey, J. Piachaud, C. Gilvarry

    
  • ·FC10.02 Deinstitutionalisation, living situation and subjective satisfaction of schizophrenic patients

    Página :291-291

    Th.W. Kallert, M. Leiße

    
  • ·FC10.03 A contolled clinical trial of intensive home treatment for persons with severe mental illness

    Página :291-292

    K.R. Lloyd, M. Cleary, C. Pearson, R. Brooks

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC10.04 Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres

    Página :292-292

    D. Wiersma, J. Wanderling, E. Dragomirecka, K. Ganev, G. Harrison, W. an der Heiden, F.J. Nienhuis, D. Walsh

    
  • ·FC10.05 Do community based mental health care networks neglect mentally ill homeless people?

    Página :292-292

    H.J. Salize

    
  • ·FC10.06 What is a psychiatrist? What are they really doing? A qualitative study combining focus groups and work sampling

    Página :292-292

    M. Munarriz, C. Santiago, M.J. Marques, J. Sanjuan, M. Gomez-Beneyto

    
  • ·DE03.01 Should-second generation antipsychotics be favored over traditional neuroleptics in the treatment of patients with schizophrenia?

    Página :292-293

    W.W. Fleischhacker

    Resumen Resumen Esquema Esquema

• Symposia

  • ·DE03.02 Contra

    Página :293-293

    L. Farde

    
  • ·SES15.01 A critical review in the work with severely traumatized

    Página :293-293

    M. Kastrup

    
  • ·SES15.02 Torture and the role of the physician — A historical and transcultural overview

    Página :293-293

    I. Sibitz, T. Wenzel

    
  • ·SES15.03 Treatment services for survivors of torture: A transcultural study

    Página :293-293

    T. Wenzel, A. Zoghlami, H. Griengl, W. Brause, I. Genefke

    
  • ·SES15.04 New approaches to the rehabilitation of torture victims in Hungary

    Página :293-293

    L. Hárdi, E. Kalamár

    
  • ·SES16.01 The future pattern of psychiatric provision in England

    Página :293-293

    D. Goldberg

    
  • ·SES16.02 Worrying indicators in schizophrenia treatment

    Página :293-293

    P. Munk-Jørgensen

    
  • ·SES16.03 Deinstitutionalization in Germany and Switzerland

    Página :294-294

    H.-J. Haug, W. Rössler

    
  • ·SES16.04 Deinstitutionalisation and psychiatric reform in Spain

    Página :294-294

    J.L. Vázquez-Barquero, J. Garcia

    
  • ·S39.01 Can better recognition and treatment of depression reduce suicide rates?

    Página :294-294

    Z. Rihmer

    
  • ·S39.02 Prevention of suicide and suicide attempt by adequate lithium long-term treatment

    Página :294-295

    B. Mueller-Oerlinghausen

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S39.03 Clozapine and suicide prevention in schizophrenia

    Página :295-295

    M. Jakovljevi

    
  • ·S39.04 Prevention of suicides by long-term treatment with anti-depressants?

    Página :295-295

    J. Angst, F. Angst, H.H. Stassen, P.J. Clayton

    
  • ·S40.01 Psychiatry of extremal situation

    Página :295-295

    V.N. Krasnov

    
  • ·S40.02 Mental disorders in refugees

    Página :295-296

    Z.I. Kekelidze, D.P. Demonova

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S40.03 Psychological defense and psychopathological disorders in victims of the Armenian earthquake of 1988

    Página :296-296

    M. Melik-Pashayan, K. Gasparyan

    
  • ·S40.04 Realistic evaluation of psychiatrical consequences of chernobyl accident

    Página :296-296

    V. Skavych

    
  • ·S41.01 A 2.5 year follow-up study of the efficiency of psychotherapeutic treatment of eating disorders

    Página :296-296

    J. Treasure, H. Kordy

    
  • ·S41.02 Motivation in eating disorders: Is it more than a fashion?

    Página :296-297

    U. Schmidt

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S41.03 Diagnostic subgroups in eating disorders related to pain threshold

    Página :297-297

    H. Papežová, A. Yamamotová

    
  • ·S41.04 When the body speaks: The cultural context of eating disorders

    Página :297-297

    M. Katzman

    
  • ·S41.05 Guidelines for pharmacotherapy

    Página :297-297

    T. Bruna

    
  • ·C02.01 Interpersonal psychotherapy (IPT)

    Página :297-297

    E. Schramm

    
  • ·C06.01 Developing programmes against stigma and discrimination because of schizophrenia

    Página :297-298

    N. Sartorius, J.J. Lopez-Ibor, W. Gaebel, W. Schöny, G. Rossi

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC11.01 Phenomenology of schizophrenia in different gender

    Página :298-298

    M. Afzal Javed

    
  • ·FC11.02 The language of schizophrenia in XXth century: From phenomenological to illocutionary approach

    Página :298-298

    J. Zislin, V. Kuperman, R. Durst

    
  • ·FC11.03 Four-year stability of positive and negative schizotypal traits in normal adolescents from the general population

    Página :298-299

    N. Barrantes-Vidal, J.E. Obiols

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC11.04 A cluster analytic study of normal adolescents with neurodevelopmental neurocognitive, personality and social risk factors for schizophrenia spectrum disorders

    Página :299-299

    N. Barrantes-Vidal, A. Rosa, L. Fananas, J.E. Obiols

    
  • ·FC11.05 Hubin — human brain informatics: A clinical database project for multidisciplinary research in schizophrenia

    Página :299-299

    H. Hall, T. McNeil, S. Arnborg, I. Agartz, U. Ösby, J. Linder

    
  • ·FC11.06 A unified hypothesis of schizophrenia based on glutathione deficit

    Página :299-299

    M. Kirsten-Krüger, K.Q. Do, A.H. Trabesinger, C.J. Lauer, U. Dydak, D. Hell, F. Holsboer, P. Boesiger, M. Cuéod

    
  • ·SES17.01 Psychopathological phenotypes

    Página :300-300

    W.M.A. Verhoeven, S. Tuinier, L.M.G. Curfs

    
  • ·SES17.02 Behavioural phenotypes in different forms of X-linked mental retardation

    Página :300-300

    J.P. Fryns, M. Borghgraef, S. Frints, J. Steyaert, L.M.G. Curfs

    
  • ·SES17.03 Behavioural phenotypes in clinical practice

    Página :300-300

    L.M.G. Curfs, W.M.A. Verhoeven, S. Tuinier, J.P. Fryns

    
  • ·SES17.04 The behavioural phenotypes of genetic syndromes

    Página :300-300

    A.J. Holland

    
  • ·S42.01 Prodromal symptoms in schizophrenia: State of the art

    Página :300-301

    W. Gaebel, M. Jänner, N. Frommann

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S42.02 Structural brain abnormalities in schizophrenia in relation to outcome

    Página :301-301

    W.G. Staal, H.E. Hulshoff Pol, H.G. Schnack, R.S. Kahn

    
  • ·S42.03 Test of serotonergic activity in the brain predicts therapeutic response of patients with schizophrenia

    Página :301-301

    J. Libiger, P. Mohr, J. Horáček, P. Czobor, R. Bahbouch

    
  • ·S42.04 Predicting long term recovery in schizophrenia: Findings from the International study of schizophrenia

    Página :301-301

    G. Harrison

    
  • ·S42.05 The predictability of adult individuals psychosocial characteristics on the basis of IQ and personality traits assessed in childhood

    Página :302-302

    L. Kubicka

    
  • ·S43.01 Social environment and suicidal behavior

    Página :302-302

    N. Okribelashvivi, S. Vashadze

    
  • ·S43.02 Epidemiological study of parasuicides in the city of Minsk in Belarus

    Página :302-302

    V. Poznyak, H. Ziborova, K. Rounets, L. Korolik, A. Popkov, P. Rynkov, E. Lasy, Z. Tereshkovitch

    
  • ·S43.03 Suicides in Lithuania

    Página :302-302

    R. Aranauskas

    
  • ·S44.01 Diagnosis and psychopathology: What defines a disorder?

    Página :302-303

    N.C. Andreasen

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S44.02 Cultural framework of psychiatric diagnosis

    Página :303-303

    J.E. Mezzich

    
  • ·S44.03 Psychopathology and the WHO instruments for clinical assessment

    Página :303-303

    C.B. Pull, J.M. Cloos

    
  • ·S44.04 Patients express, psychiatrists interpret, what about the diagnostic categories? The issue of anxiety comorbid with depression in Turkey

    Página :303-303

    L. Küey

    
  • ·S44.05 Psychopathology, still the core of psychiatry

    Página :303-303

    P. Smolik

    
  • ·S45.01 Epidemiology of eating disorders

    Página :304-304

    H.W. Hoek, D. van Hoeken

    
  • ·S45.02 The course of eating disorders (AN, BN, BED): Predictors, risk factors and causal models

    Página :304-304

    M.M. Fichter, N. Quadflieg, J. Rehm

    
  • ·S45.03 Emotional model in eating disorders

    Página :304-304

    J. Treasure, N. Troop, A. Bond, T. Murphy, U. Schmidt

    
  • ·S45.04 Body image in eating disorders

    Página :304-304

    F. Fernández-Aranda

    
  • ·S45.05 Body image disturbances in obesity before and after weight loss

    Página :304-305

    M. Cuzzolaro, G. Vetrone, G. Marano

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC12.01 Risperidone for chronic schizophrenic patients on depot neuroleptics: A detailed clinical audit and switch study

    Página :305-305

    L. Conlon, J. Gilligan, T.J. Fahy

    
  • ·FC12.02 Could the schizotypal features explain the equivocal findings of the Wisconsin card sorting test in the first-degree relatives of patients with schizophrenia?

    Página :305-305

    A. Laurent, D. Bourdery, P. Séchier, T. Bougerol, T. D'Amato, J. Dalery

    
  • ·FC12.03 Recent dermatoglyphic studies in twin samples: Further evidences for an environmental risk factor in schizophrenia

    Página :305-306

    A. Rosa, L. Fañanás, A. Mcdonald, H.S. Bracha, B. Arias, E.F. Torrey, R.M. Murray, J. van Os

    Resumen Resumen Esquema Esquema

• Symposia

  • ·FC12.04 May P300 help differentiate the syndromatic patterns in schizophrenia?

    Página :306-306

    J. Maltez, N. Alves, J.P. Foreid, T. Pimentel, M. Abreu

    
  • ·FC12.05 Smoking in schizophrenia: Prevalence and associated features

    Página :306-306

    M. Gurpegui, M.C. Aguilar, J. de Leon

    
  • ·FC12.06 Alien voices: Does dysfunctional self-monitoring explain auditory hallucinations in schizophrenia?

    Página :306-307

    C.H.Y. Fu, M.J. Brammer, E. Amaro, S.C.R. Williams, N. Vythelingum, C. Andrew

    Resumen Resumen Esquema Esquema

• Symposia

  • ·SAT02.01 Making remission an achievable goal — specialist's utopia versus generalist's reality?

    Página :307-307

    A. Wade

    
  • ·SAT02.02 Optimising long-term treatment of depression

    Página :307-307

    Y. Lecrubier

    
  • ·SAT02.03 Quality of life issues in long-term treatment with antidepressants

    Página :307-307

    P. Bech

    
  • ·SAT02.04 Maintaining response to antidepressants

    Página :307-307

    M. Lader

    
  • ·S46.01 Consultation-liaison psychiatry, primary and secondary care

    Página :307-307

    A. Lobo

    
  • ·S46.02 Quality management, accreditation and certification processes in C-L psychiatry

    Página :307-308

    M. Rigatelli, B. Bertoncelli

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S46.03 Consultation-liaison psychiatry in Europe: Current issues — The importance of cost-effectiveness studies

    Página :308-308

    F. Creed

    
  • ·S46.04 Consultation-liaison psychiatry and psychosomatics: Quality management and guideline development — A European perspective

    Página :308-308

    T. Herzog

    
  • ·S47.01 Abulia following brain injury

    Página :308-308

    K. Barrett

    
  • ·S47.02 Treatment of affective disorders after brain injury

    Página :308-308

    P. Eames

    
  • ·S47.03 Pharmacotherapy of neuropsychiatric disorders following brain injury

    Página :308-309

    U. Müller

    Resumen Resumen Esquema Esquema

• Symposia

  • ·S47.04 Psychopathology following brain injury; Impact on return to work

    Página :309-309

    P. North

    
  • ·S48.01 Quality in accreditation to the excellence

    Página :309-309

    G.V. Rossi, A. Erlicher, C. Barbini, A. Righi

    
  • ·S48.02 How to state procedures in mental health: The genoa department of mental health experience

    Página :309-309

    L. Ferrannini, G. Boidi, P. Ciancaglini

    
  • ·S48.03 Ideologies and accreditations

    Página :309-309

    F.A. Jenner

    
  • ·S48.04 Standardised description of psychiatric care. The need to place every service in its specific context

    Página :309-309

    G. Tibaldi, C. Munizza

    
  • ·S49.01 Atypical antipsychotics in schizoaffective disorders

    Página :309-309

    S. Montgomery

    
  • ·S49.02 Atypical antipsychotics in bipolar disorder

    Página :309-309

    
  • ·S49.03 Atypical antipsychotics in resistant depression, delusion depression

    Página :310-310

    S. Kasper

    
  • ·S49.04 Impact of neurotic symptoms on the response to 4 years treatment with clozapine in drug resistant psychotic patients

    Página :310-310

    G.B. Cassano, A. Ciapparelli

    
  • ·S49.05 Atypical antipsychotics in neurology (Parkinson, tourette, dementia, etc)

    Página :310-310

    
  • ·S50.01 Assessment of disablement in schizophrenia

    Página :310-310

    H.W. Hoek, K. van Hoof, D. van Hoeken, M. van der Gaag

    
  • ·S50.02 The influence of personality on the assessment of disablement

    Página :310-310

    N. Glozier

    
  • ·S50.03 Disability in mental and physical patients

    Página :310-310

    J.L. Vázquez-Barquero, S. Herrera Castanedo, M.E. Vázquez Bourgon, L. Cardenal, A. Gómez, M. Uriarte

    
  • ·S50.04 Disability and disability assessment in anxiety disorders

    Página :310-310

    C.B. Pull, J.M. Cloos, P. Straus, A. Sztantics, M.C. Pull

    
  • ·S51.01 The odin project: Study design and instruments

    Página :311-311

    J.L. Ayuso-Mateos, J.L. Vazquez-Barquero

    
  • ·S51.02 Urban-rural differences in the prevalence of depression in Europe: Evidence from the odin project

    Página :311-311

    V. Lehtinen, E. Michalak, C. Wilkinson, C. Dowrick, J.L. AyusoMateos, O.S. Dalgard, P. Casey, J.L. Vazquez-Barquero, G. ilkinson

    
  • ·S51.03 Negative life events, social support and depression in the odin study

    Página :311-311

    O.S. Dalgard

    
  • ·S51.04 Personality factors in depressive disorders

    Página :311-311

    A. Horgan, P. Casey

    
  • ·S51.05 Trial of psychological intervention in the community

    Página :311-311

    C. Dowrick

    
  • ·W05.01 Mental health care in Hungary

    Página :311-311

    I. Bitter

    
  • ·W05.02 Current trends in czech psychiatry

    Página :311-311

    J. Raboch, P. Baudiš

    
  • ·W05.03 Future perspectives of Swiss psychiatry

    Página :311-311

    W. Rössler

    
  • ·W05.04 Follow-up of changes of psychiatric care (intra- and extramural)

    Página :312-312

    G. Hofmann

    
  • ·WPA.01 The use of the WPA/PTD educational programme on the recognition and treatment of depressive disorders

    Página :312-312

    N. Stefanis, J.E. Cooper, N. Kornetov

    
  • ·FC13.01 Severe mental illness and airports — The scope of the problem

    Página :312-312

    B.B. Lucas, U.C. Wieshmann, M. Anjoyeb

    
  • ·FC13.02 Utilisation of emergency departments by substance abusers: Drug-related problems in a multicentric epidemiological study in France

    Página :312-313

    P. Nuss, M. Ferreril, P. Espinoza, F. Mathyz

    Resumen Resumen Esquema Esquema
  • ·FC13.03 The recognition of common mental disorder by non-psychiatric physicians in Taiwan

    Página :313-313

    S.-I. Liu, A. Mann

    
  • ·FC13.04 Unplanned discharge in a psychiatric day clinic — Trying to differentiate the reasons

    Página :313-313

    P. Garlipp, K.-P. Seidler, K. Amini, W. Machleidt, H. Haltenhof

    
  • ·FC13.05 Predicting admissions in emergency psychiatry

    Página :313-313

    C.L. Mulder, P.C.A. van der Graafi, P. de Jonge, A.A. de Groot, J.S. Lyons

    
  • ·FC13.06 The cross-national epidemiology of unexplained chronic fatigue

    Página :313-314

    P. Skapinakis, G. Lewis, V. Mavreas

    Resumen Resumen Esquema Esquema
  • ·PS04.01 Pharmacological treatment of schizophrenia

    Página :314-314

    W.W. Fleischhacker

    
  • ·PS04.02 Psychosocial treatment

    Página :314-314

    J. Left

    
  • ·PS04.03 Rehabilitation

    Página :314-314

    W. Rossler

    
  • ·S52.01 Cerebral MRI findings in schizophrenia: A review of the evidence

    Página :315-315

    A. Vita, M. Dieu, L. Delen, F. Tenconi

    
  • ·S52.02 Structural changes in first-episode schizophrenia

    Página :315-315

    E. Ceskova, B. Prokes, M. Lorenc, P. Drybcak, M. Ondrusova

    
  • ·S52.03 Pet studies of cognition and emotion in schizophrenia

    Página :315-315

    N.C. Andreasen

    
  • ·S52.04 Functional spect findings in schizophrenia

    Página :315-315

    S. Kasper

    
  • ·S52.05 The role of rCBF (99Tc HMPAO) measurements in the assessment of a psychiatric patient

    Página :315-315

    J. Libiger, M. Kopecek, A. Urban, K. Kupka

    
  • ·S53.01 Prodromes of relapse and first episode of psychoses: Different or same?

    Página :316-316

    M. Birchwood

    
  • ·S53.02 Cognitive and behavioral functioning during the decade prior to first hospitalization and during early course of schizophrenic illness

    Página :316-316

    M. Davidson

    
  • ·S53.03 Vulnerability markers and prediction of imminent psychosis

    Página :316-316

    P. Jones

    
  • ·S53.04 The cologne early recognition project

    Página :316-316

    J. Klosterkotter

    
  • ·S53.05 Screening and describing subjects with prodromals to schizophrenia

    Página :316-316

    R.K.R. Salokangas, M. Heinimaal, T. Ilonen, T. Suomelal, M. Korkeilal, M. Plathin, T. Ristkaril, J. Huttunen, J. Hietala, E. Syvilahti, T.H. McGlashan

    
  • ·SES18.01 Personality dimensions in affective disorders

    Página :316-316

    P. Pichot

    
  • ·SES18.02 The ICS-10 personality disorders relevant for affective disorders

    Página :316-316

    C. Pull

    
  • ·SES18.03 Bipolar personality dimensions and the choice of mood stabilizers in long-term treatment

    Página :317-317

    H.S. Akiskal

    
  • ·SES18.04 Personality dimensions as predictors of treatment outcome in affective disorders

    Página :317-317

    P. Tyrer, H. Seivewright, T. Johnson

    
  • ·SES18.05 Treatment of social phobia: The association of personality and affective symptoms

    Página :317-317

    P. Bech

    
  • ·S54.01 The pathopysiology of formal thought disorder

    Página :317-317

    T.T.J. Kircher, P.F. Liddle, M. Brammer, S.C.R. Williams, R.M. Murray, P.K. McGuire

    
  • ·S54.02 Using pet to study dopamine release in vivo

    Página :317-318

    P.M. Grasby, C. Bench, M. Knepp, R. Gunn, C. Messa

    Resumen Resumen Esquema Esquema
  • ·S54.03 Functional anatomy of auditory hallucinations

    Página :318-318

    P.K. McGuire

    
  • ·S54.04 A system model of altered consciousness: Integrating natural and drug-induced psychoses

    Página :318-318

    F.X. Vollenweiderl, K.L. Leenders, Ch. Scharfetterl, D. Hell

    
  • ·S55.01 Depression in Tunisia: Another gender inequality?

    Página :318-318

    S. Douki

    
  • ·S55.02 Postpartum depression: A prospective study

    Página :318-318

    D. Moussaoui

    
  • ·S55.03 PMS/PMDD: Diagnosis and treatment

    Página :318-318

    M. Steiner

    
  • ·S55.04 Premenstrual in the general population: An epidemiological study

    Página :318-318

    N. Kadiri

    
  • ·W15.01 When physicians commit suicide: Reflections of those they leave behind (videotape)

    Página :319-319

    M.F. Myers

    
  • ·FC14.01 The predictability of adult individuals' psychosocial characteristics on the basis of IQ and personality traits assessed in childhood

    Página :319-319

    L. Kubicka, Z. Dytrych, Z. Matejcek, Z. Roth

    
  • ·FC14.02 Child psychiatric disorders — A community sample

    Página :319-319

    V. Eapen, M.E. Jakkal, M.T. Abou-Saleh

    
  • ·FC14.03 Assertive community treatment: Ethical and legal dilemmas

    Página :319-319

    J. Stovall

    
  • ·FC14.04 The defence mechanism test in panic disorder, generalized anxiety disorder and schizophrenia

    Página :319-320

    L. Bogren, I.-B. Bogren

    Resumen Resumen Esquema Esquema
  • ·FC14.05 Anxiety and personality correlates in patient with somatoform disorder

    Página :320-320

    C. Pruneril, E. Pellegrini, S. Damiano, F. Furlani

    
  • ·FC14.06 Personality tests assesment in a selected cohort of french applicants for sex reassignement linked to the problem of sexual identity

    Página :320-320

    T. Gallarda, S. Coussinoux, B. Cordier, M. Haddou, I. Amado, M.F. Poirier, M.C. Bourdel, J.P. Olie

    
  • ·P01.01 The somatic etiology of cycloid psychoses

    Página :321-321

    E. Franzek

    
  • ·P01.02 Light therapy for treatment indications other than seasonal affective disorder

    Página :321-321

    A. Neumeister, A. Graf, M. Willeit, S. Kasper

    
  • ·P01.03 The correlation between work psychopatology and migration

    Página :321-321

    M. Mattia

    
  • ·P01.04 Training of future psychiatrists for psychotherapeutic work with psychotic patients

    Página :321-321

    M. Patris, Ph. Amarilli

    
  • ·P01.05 Clinical validity of ICD-l0 neurasthenia

    Página :322-322

    B. Bankier, M. Aigner, A. Spacek, S. Krones, M. Bach

    
  • ·P01.06 Alexithymia in DSM-IV disorder: Comparative evaluation in somatoform disorders, panic disorder, obsessive-compulsive disorder, and depression

    Página :322-322

    B. Bankier, M. Aigner, U. Demal, M. Bach

    
  • ·P01.07 Rem-sleep behavior disorder in the elderly

    Página :322-322

    H. Chiu, L. Lam

    
  • ·P01.08 Depressive mixed state in atypical depression

    Página :322-322

    F. Benazzi

    
  • ·P01.09 The intellectual development, mental and behavioral disorders in the children from belarus exposed in utero following the chernobyl accident

    Página :323-323

    S. Igumnov, V. Drozdovitchl

    
  • ·P01.10 Elderly men loneliness: Contribution into development of psychological and sexual isolation

    Página :323-323

    M. Yagoubov

    
  • ·P01.11 Distribution and drinking patterns in seamen in the European North of Russia

    Página :323-323

    A.G. Kalinin, P.I. Sidorov, O. Nilssen, T. Brenn

    
  • ·P01.12 Ethic decisions on involuntary treatment of patients with schizophrenia

    Página :323-324

    T. Steinert, D. Herforth, R.P Gebhardt

    Resumen Resumen Esquema Esquema
  • ·P01.13 Clinical and eeg predictors of the therapepeutic outcome of electroconvulsive therapy

    Página :324-324

    M. Hrdlicka, M. Blatny, M. Moran, J. Vachutka, J. Rozinkova

    
  • ·P01.14 Olanzapine: Effects on neuropsychological test performances in the schizophrenic spectrum

    Página :324-324

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    
  • ·P01.15 Neurocognitive changes in adjustment disorder with depressed mood: Use of paroxetine

    Página :324-324

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    
  • ·P01.16 Gabapentin in antipsychotic-induced movements

    Página :324-325

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    Resumen Resumen Esquema Esquema
  • ·P01.17 Adjunctive amisulpride to fluvoxamine in major depression: Early ssri onset of action

    Página :325-325

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    
  • ·P01.18 Role of pro-inflammatory cytokines in down's syndrome

    Página :325-325

    M.G. Carta, M.C. Hardoy, P.E. Manconil, P. Serra, A. Barrancal, C.M. Caffarelli, E. Mancal, A. Ghianil

    
  • ·P01.19 Lack of effects of st john's wort extract on autonomic and cognitive functions

    Página :325-325

    M. Siepmann, M. Muck-Weymann, P. Joraschkyl, W. Kirch

    
  • ·P01.20 Comparison of effects of panic disorder with agoraphobia in men and women

    Página :326-326

    M. Latast, V. Starcevicz, A. jordjevic

    
  • ·P01.21 Augmantation with d2 antagonists for partial reponders to atypical antipsychotics

    Página :326-326

    D. Mazeh, Y. Melamed, A. Elizur

    
  • ·P01.22 Predictors of chronicity and health service use in patients presenting unexplained physical symptoms

    Página :326-326

    R.E. Taylor, D.P Goldberg, A.H. Mann

    
  • ·P01.23 Compliance inventory (CI-6)

    Página :326-326

    R.-P. Gebhardt, T. Steinert, M. Wölfle

    
  • ·P01.24 Proximity to the community or specialisation of psychiatric in-patient care (part 1)

    Página :327-327

    R.-P Gebhardt, M. Wolfle, P.-O. Schmidt-Michel

    
  • ·P01.25 The motivations for opiate use among addicts of shiraz self-identified center

    Página :327-327

    A. Ghanizade, J. Ahmadi

    
  • ·P01.26 The effect of cultural factors on students' drug use

    Página :327-327

    A. Ghanizadeh

    
  • ·P01.27 A comparison of two different instruments assessing the individual need for care

    Página :327-328

    G. Spinner, R.P. Gebhardt

    Resumen Resumen Esquema Esquema
  • ·P01.28 Effects of new antipsychotics on serum prolactin and testosterone level in schizophrenic patients

    Página :328-328

    D. Han, D. Park, C. Na

    
  • ·P01.29 Psychiatry in intelectual disability: The tools of care” in Geneva

    Página :328-328

    M.F. Kummer, G. Carminati

    
  • ·P01.30 Altered biochemical bone remodelling markers in schizophrenia

    Página :328-328

    A. Herran, M.T. Garcia-Unzueta, J.A. Amado, J. GonzalezMacias, L. Perera, J.L. Vázquez-Barquero

    
  • ·P01.31 Functional relationship between enzymes MAOA and ace in human brain?

    Página :328-329

    O. Šerý, V. Znojil, V. Mikeš, P. Zvolsky

    Resumen Resumen Esquema Esquema
  • ·P01.32 Social factors and women's mental health in Russia

    Página :329-329

    T. Dmitrieva, M. Kachaeva

    
  • ·P01.33 Event related potentials and neuropsychological tests in obsessive-compulsive disorder

    Página :329-329

    B.B. Kivircik, G.G. Yener, K. Alptekin, O.C. Eigin, H. Aydin

    
  • ·P01.34 Disability pension among psychiatric outpatients with major depression

    Página :329-329

    M. Sorvaniemi, H. Helenius, R.K.R. Salokangas

    
  • ·P01.35 Aggresion in mild retarded people as family problem reflection

    Página :329-330

    S. Betskov, E. Krivulin

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.40 Efficacy of venlafaxine in depressed patients after switching from prior SSRI treatment

    Página :331-331

    C. Reynaert, P. Janne, N. Zdanowics, A. Mignon

    
  • ·P01.41 Efficacy of venlafaxine in depressed patients after failure with prior antidepressant treatment

    Página :331-331

    M. De Clercq, A. Mignon

    
  • ·P01.42 Symptom relief obtained with venlafaxine versus fluoxetine in depressed patients with concomitant anxiety

    Página :331-331

    A. De Nayer, M. De Clercq, A. Mignon

    
  • ·P01.43 Dopamine transporter genotypes and imaging in tourette disorder

    Página :332-332

    P. Schüssler, M. Stamenkovic, S.-D. Schindler, S. Asenbaum, K. Fuchs, F. Leisch, F. Riederer, W. Sieghart, S. Kasper, K. Hornik, H.N. Aschauer

    
  • ·P01.44 Obsessional-compulsive symptoms in four groups of eating disorders screened by SCL-90

    Página :332-332

    M. Campana, P. Colleoni, P. Drago, M. Nava, M. Riglietta, L. Tidone

    
  • ·P01.45 Evaluation of psychiatric co-morbidity in a group of binge eating disorders screened by SCL-90

    Página :332-332

    M. Carnpana, P. Colleoni, P. Drago, M. Nava, M. Riglietta, L. Tidone

    
  • ·P01.46 Prevalence and severity of psychiatric co-morbidity in different addictive disorders

    Página :333-333

    M. Riglietta, M. Campana, P. Drago, M. Fusini, L. Tidone

    
  • ·P01.47 The European long and short term amisulpride (ELSA) study. AN international comparative study on the utilisation of amisulpride in routine care

    Página :333-333

    M. Linden, G. Agnes

    
  • ·P01.48 Dimensions of psychopathology in schizophrenia: A factor analysis of the amisulpride database

    Página :333-333

    W. Rein

    
  • ·P01.49 Low dose amisulpride: Some evidence for alertness-increasing properties in EEG studies

    Página :334-334

    E. Legangneux, P. Rosenzweig, B. Saletu, H. Allain

    
  • ·P01.50 Alcoholics life quality evaluation

    Página :334-334

    P.I. Sidorov, A.G. Soloviev

    
  • ·P01.51 Medical follow-up of attempters in the year preceding suicide

    Página :334-334

    F. Chastang, L. Leclerc, P. Rioux, V. Kovess, E. Zarifian

    
  • ·P01.52 The efficacy and safety of risperidon in children with autistic disorder

    Página :334-334

    R.S. Dýler, S. Firat, A. Avcil

    
  • ·P01.53 Psychotherapy in the correction of sexual disharmony

    Página :335-335

    M.V Markova

    
  • ·P01.54 Posttraumatic stress disorders (PTSD) in Ukraine

    Página :335-335

    B.V Mykhaylov, V.G. Cherkasov, U.N. Astapov

    
  • ·P01.55 Agression and strategic problems of psychiatry in Ukraine

    Página :335-335

    A.I. Serdyuk, B.V Mykhaylov

    
  • ·P01.56 Gamma-hydroxy buthyric acid (alcover) in the treatment of alcohol withdrawal syndrome

    Página :335-335

    L. Kovács, G. Kovács

    
  • ·P01.57 The cultural context of psychostimulant use

    Página :335-336

    Zs. Demetrovics

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.58 Lack of effect of vitamin B₆ on psychotic symptoms in chronic schizophrenic and schizoaffective patients: a double-blind placebo-controlled study

    Página :336-336

    V. Lerner, C. Miodownik, A. Kaptsan, H. Cohen, M. Matar, U. Lowenthal, M. Kotler

    
  • ·P01.59 Is prescription of cyamemazine useful to favor withdrawal of benzodiazepines after long term treatment?

    Página :336-336

    P. Lemoine, F. d'Alché-Birée, S. Garcia-Acosta, M. Dib

    
  • ·P01.60 What's beneath the skin?

    Página :336-336

    M. Moretti, T. Kurimay

    
  • ·P01.61 Study of conversion factor between zuclopenthixol (ZCP) acetate and ZCP decanoate in patients receiving high doses of ZCP acetate

    Página :336-337

    F.R. Cousin, C. Gury

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.62 Efficacy of venlafaxine er in gad patients with predominantly somatic symptomatology

    Página :337-337

    D. Hackett, J. Rasmussen, P. Meoni

    
  • ·P01.63 Venlafaxine er action on generalized anxiety disorder (GAD)-specific anxiety symptoms

    Página :337-337

    P. Meoni, D. Hackett, Y. Brault, E.O. Salinas

    
  • ·P01.64 Quality of response in GAD: is response to placebo the same as response to active treatment?

    Página :337-337

    P. Meoni, D. Hackett, C. White

    
  • ·P01.65 Beliefs about depression and outcome in major depression: A pilot study

    Página :338-338

    P.L. Cornwall, B.R. Pollinger, M. Pope

    
  • ·P01.66 Case report: Sexual offending in a man with aspergers syndrome, XYY syndrome and a seizure disorder

    Página :338-338

    K.P Courtenay, J. Bird

    
  • ·P01.67 Case report: Prader-willi syndrome and bipolar affective disorder with psychosis

    Página :338-338

    K.P. Courtenay, L. Magrill

    
  • ·P01.68 Current and residual functional disability associated with psychopathology. Findings from the Netherlands mental health survey and incidence study (NEMESIS)

    Página :338-338

    R.V. Bijl

    
  • ·P01.69 Multiple sclerosis and eating disorders

    Página :338-339

    D. Kountouris

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.70 Oxcarbazepine as a mood regulator: Its efficacy, safety and tolerability versus carbamazepine

    Página :339-339

    G. Tavormina

    
  • ·P01.71 Help-seeking behaviour and coping preceding first psychiatric admission of psychosis patients

    Página :339-339

    J. Fuchs, T. Steinert

    
  • ·P01.72 Psychosocial status of female transsexuals after surgical sex reassignment

    Página :339-339

    L. Vasilenko, L. Gorobetz

    
  • ·P01.73 Socio-invironmental factors and neurotic disorders among children

    Página :340-340

    N.K. Suchotina

    
  • ·P01.74 Loneliness states and associated with them disorders of depressive spectrum beside persons of late age

    Página :340-340

    J. Polichtchouk, L. Golubtsova, V. Gurvich, A. Kolpakov

    
  • ·P01.75 Correlation of the anticonvulsant using in psychiatric clinic of the epileptology center

    Página :340-340

    E. Maxoutova, E. Jeleznova, L. Sokolova, A. Zemlyanaya

    
  • ·P01.76 Use of dalargin in the treatment of compulsive craving in opiate addiction

    Página :340-340

    S. Matevosyan, A. Belkin

    
  • ·P01.77 Multifactorial psychological study of somatoform disorders

    Página :341-341

    A. Kholmogorova, N. Garanian, P. Sheib, M. Wiersching

    
  • ·P01.78 Familial context of somatoform disorders

    Página :341-341

    A. Kholmogorova, S. Volikova

    
  • ·P01.79 Social consequences of heroin addiction

    Página :341-341

    L.A. Tchistyakova

    
  • ·P01.80 Industrial rehabilitation and psychological protection

    Página :341-341

    P. Pyrkov

    
  • ·P01.81 Clinical features of female heroin addiction

    Página :341-342

    S.O. Mokhnatchev

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.82 Dependence of medical and social consequences of drug addiction on predisposing factors

    Página :342-342

    A.A. Kozlov

    
  • ·P01.83 Degrees of mental disorder in vasqulocerebral pathology

    Página :342-342

    G. Kindras, L. Borisova, R. Kondratenko, D. Ogar

    
  • ·P01.84 Neurofibromatosis type 1: Neuropsychology and MRI correlates

    Página :342-342

    R. Feldmann, M. Oelerich, T. Allkemper, U. Wiegard, M. Pietsch, J. Weglage

    
  • ·P01.85 Addictions: Situation in belarus by 2000

    Página :343-343

    O. Liskovski

    
  • ·P01.86 Preliminary results from the international personality disorders examination (IPDE) field trial in Greece

    Página :343-343

    K.N. Fountoulakis, A. Iacovides, C. loannidou, F. Bassala, G. Kaprinis

    
  • ·P01.87 Dexamethasone suppression test, personality disorders and stressful life events in clinical subtypes of major depression

    Página :343-343

    K.N. Fountoulakis, A. lacovides, F. Fotiou, M. Karamouzis, A. Demetriadou, G. Kaprinis

    
  • ·P01.88 Attempted suicide by hanging in young children

    Página :343-343

    S.M. Stein, N. Chalhoub, C. Masterson

    
  • ·P01.89 Applying the work of wilfred bion to the treatment of psychotic adolescents

    Página :344-344

    S.M. Stein

    
  • ·P01.90 Effects of clozapine on autonomic functions: Non-invasive biomonitoring from the skin

    Página :344-344

    M. Mueck-Weymann, J. Acker, T. Rechlin, P. Joraschky

    
  • ·P01.91 Behavioural genetics of cognitive disturbances in schizophrenia

    Página :344-344

    M.V. Alfimova, L.G. Uvarova, V.I. Trubnikov

    
  • ·P01.92 Multicenter double bind randomized oarralkel-group clinical trial of effectiveness of the combinaion clomipramine plus lithium carbonate versus clomipramine plus placebo in the treatment of unipolar depression

    Página :344-345

    D. Januel, M.-F. Poirier, F. D'Alche-Biree, M. Dib, J.-P. Olie

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.93 The networking model in the prevention of child abuse and neglect

    Página :345-345

    M. Pejovic Milovancevic, O. Vidojevic, V. Ispanovic Radojkovic, T. Mincic

    
  • ·P01.94 First episode of schizophrenia — Efifcacy of olanzapine as first choice neuroleptic

    Página :345-345

    D. Prelipceanu, R. Mihailescu, C. Andreescu

    
  • ·P01.95 Psychosocial correlates of endocrine disease: The integration of different criteria

    Página :345-345

    N. Sonino, C. Ruini, F. Ottolini, C. Navarrini, G.A. Fava

    
  • ·P01.96 Quality of life profile in patients with suicidal activity (ideation or attempt)

    Página :345-346

    C. Fenández, P.A. Sáiz, J.C. González, M.P. González, Y. Ramos, M. Bousoño

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.97 Health status and elderly people

    Página :346-346

    P.A. Sáiz, Ma.P. Gonzilez, J.Ma. Fernindez, S. Martinez, Ma.T. Bascarán, J. Bobes

    
  • ·P01.98 Apolipoprotein e genotype and schizophrenia

    Página :346-346

    P.A. Sáiz, M. Gonzilez-Quiros, V. Alvárez, E. Coto, J.Ma. Fernández, M. Bousoño

    
  • ·P01.99 Suicidal behaviour and the tryptophan hidroxylase and the apolipoprotein E genes polymorphisms

    Página :346-346

    P.A. Sáiz, B. Morales, M. Gonzilez-Quiros, V. Alvárez, E. Coto, J.Ma. Fernández, M. Bousoño

    
  • ·P01.100 Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with alzheimer's dementia

    Página :346-347

    J.S. Street, W.S. Clark, B.E. Juliar, P.D. Feldman, D.L. Kadam, A. Breier

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.101 Possible mechanisms for the efficacy of olanzapine in preventing relapse in schizophrenia

    Página :347-347

    B. Jones, C.C. Taylor

    
  • ·P01.102 Olanzapine in the prevention of psychosis among nursing home patients with behavioral disturbances associated with Azheimer's disease

    Página :347-347

    W.S. Clark, J.S. Street, T.M. Sanger, P.D. Feldman, A. Breier

    
  • ·P01.103 Activity assessments of superoxide dismutase, glutathione reductase and glutathione peroxidase in the red blood cells of Alzheimer patient's

    Página :347-347

    J. Leszek, A. Kiejna, B. Janicka, E. Trypka, R. Górna

    
  • ·P01.104 Relation of suicidal behaviour, central serotonergic system and temperament and character inventory

    Página :347-348

    U. Itzlinger, A. Heiden, J. Scharfetter, C. Gebhardt, P. Schüssler, K. Fuchs, W. Sieghart, S. Kasper, H. Aschauer

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.105 Alpha-1-acid glycoprotein and suicidality in major depressive disorder

    Página :348-348

    E. Nieto, E. Vieta, L. Alvarez, M. Torra, C. Gastó

    
  • ·P01.106 Erectile dysfunction secondary to partners vagwismus: Cultural perspective: Case reports

    Página :348-348

    M.L. Soylul, S. Uguz

    
  • ·P01.107 Proximity to the community or specialisation of psychiatric in-patient care (Part 2)

    Página :348-348

    M. Wℓfle, R.-P. Gebhardt, P.-O. Schmidt-Michel

    
  • ·P01.108 Changes of quality of life of hiv/aids patients in comparison with a control group

    Página :348-349

    J. Potribnál, E. Dragomirecká

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.109 Psychological mechanisms of sexual homicide behavior

    Página :349-349

    N. Dvorianchikov, A. Gerasimov

    
  • ·P01.110 Psychoeducation and relapse of schizophrenia

    Página :349-349

    L. Motlova, F. Spaniel, I. Vaňurová, J. Klaschkal

    
  • ·P01.111 The quality of life in panic disorder

    Página :349-350

    P. Delia-Marina

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.112 Audible thinking: A specific trait marker for schizophrenia?

    Página :350-350

    S. Lafont-Rapnouil, B. Laffy-Beaufils

    
  • ·P01.113 Inpatient service utilisation in first episode psychosis: Patterns and predictors during the first three years

    Página :350-350

    A. Sipos, G. Harrison, D. Gunnell

    
  • ·P01.114 Mental health and modern armed conflict in the chechen republic

    Página :350-350

    E. Koren

    
  • ·P01.115 Temperament and character traits in women with suicidal attempt

    Página :351-351

    T. Zujovic, B. Miljanovic, V. Tepsic

    
  • ·P01.116 Serotonin transporter and serotonin receptor genes polymorphisms in the Russian patients with schizophrenia and affective disorders

    Página :351-351

    V. Golimbet, T. Sherbatich, K. Manandyan, L. Abramova, V. Orlova, V. Kaleda, I. Oleichik, V. Bondar, Yu. Yurov, V. Trubnikov, E. Rogaev

    
  • ·P01.117 Contingent negative variation in depression: Relationship with personality

    Página :351-351

    M. Hansenne, W. Pitchot, E. Pinto, J. Reggers, M. Ansseau

    
  • ·P01.118 Event-related potential and personality in depression

    Página :351-351

    M. Hansenne, W. Pitchot, E. Pinto, J. Reggers, M. Ansseau

    
  • ·P01.119 Implication of 5HT1A receptors in male alcoholic patients

    Página :352-352

    E. Pinto, J. Reggers, W. Pitchot, M. Hansenne, S. Fuchs, M. Ansseau

    
  • ·P01.120 Electroconvulsive therapy in patients with silent cerebral infarction and major depression

    Página :352-352

    T. Zujovic, V. Tepsic, J. Antonijevic, M. Blagojevic

    
  • ·P01.121 Late-onset agranulocytosis during clozapine treatment: A case report

    Página :352-352

    L. Tamam, E. Kulan, N. Ozpoyraz

    
  • ·P01.122 Personality disorders in patients with bipolar-1 disorder

    Página :352-353

    L. Tamam, E. Kulan, N. Ozpoyraz

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.123 Comorbidity of anxiety disorders in patient with bipolar-I disorder

    Página :353-353

    L. Tamam, N. Ozpoyraz

    
  • ·P01.124 Depressive episode treatment with citalopram in patients with human immunodeficiency virus (HIV) infection: A double blind clinical study

    Página :353-353

    R. Vazquez-Noguerol, M. Alvarez, A. Perez-Bravo, J. Olivares

    
  • ·P01.125 Metachromatic leukodystrophy vs. schizophrenia: A case report

    Página :353-353

    E.G. de Miguel, J.V. Guerrero

    
  • ·P01.126 Subthreshold psychiatric disorders influence the subjective well-being of the elderly

    Página :353-353

    A. Papassotiropoulos, R. Heun

    
  • ·P01.127 Event related potentials (CNV and P300) in chronic opiate users: Preliminary results

    Página :354-354

    E. Pinto, J. Reggers, W. Pitchot, M. Hansenne, S. Fuchs, J.-J. Legros

    
  • ·P01.128 Reduced dopaminergic activity in depressed suicides

    Página :354-354

    W. Pitchot, J. Reggers, E. Pinto, M. Hansenne, S. Fuchs, M. Ansseau

    
  • ·P01.129 Three syndromes of schizophrenia — Results of an EFA - CFA - crossvalidation approach

    Página :354-354

    R.T. Schaub, R.-D. Stieglitz

    
  • ·P01.130 Alterations of gait in healthy controls compared to depressed patients treated with TCA and SSRI

    Página :354-355

    M.R. Lemke, T. Wendorff

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.131 Treatment of depression in Parkinson's disease with reboxetine

    Página :355-355

    M.R. Lemke

    
  • ·P01.132 Safety during long-term exposure to Seroquel® (quetiapine)

    Página :355-355

    A.P. Gorman, E.K. Westhead

    
  • ·P01.133 Efficacy of ‘Seroquel’ (quetiapine) compared with haloperidol and placebo in the short-term treatment of acute schizophrenia

    Página :355-355

    S.C. Schultz, A.M. Jones

    
  • ·P01.134 Plasma leptin in patients with eating disorders

    Página :356-356

    A. Tortorella, P. Monteleone, R. Ioime, V. Martiadis, M. Maj

    
  • ·P01.135 Cross-cultural aspect of alcohol use and misuse

    Página :356-356

    Y.E. Razvodovsky

    
  • ·P01.136 Relationship of schizotypal dimensions and hypomanic traits with creative thinking in normal subjects

    Página :356-356

    N. Barrantes-Vidal, J.E. Obiols

    
  • ·P01.136 Neurological abnormalities in African-Caribbean and white British first-episode psychosis patients

    Página :356-357

    F. Fonseca, P. Dazzan, K.G.D. Orr, G. Hutchinson, K.D. Morgan, J. Salvo, S. Verneals, M. Sharpley, C. Morgan, J. McCabe, B. Chapple, R. Mallett, J. Leff, R.M. Murray

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.138 The influence of familial loading on the course of schizophrenic symptoms and the success of psychoeducational therapy

    Página :357-357

    R. Feldmann, W.P. Hornung, G. Buchkremer, V. Arolt

    
  • ·P01.139 Treatment of sick doctors. The experience of a specialized unit

    Página :357-357

    A. Gual

    
  • ·P01.140 Comparison of depressive disorders in years 1990 and 1999

    Página :357-357

    E. Panagoulias, K. Dailianis, P. Papadopoulos, G. Tychopoulos

    
  • ·P01.141 Adherence to antiretroviral therapy among patients in a methadone maintenance program

    Página :357-358

    G. Perez, M. Torrens, R. Martin-Santos, C. Castillo, J. Sangorrin, M. Cabre

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.142 EEG of relatives of schizophrenics: Peculiarities and associations with cognitive and CT parameters

    Página :358-358

    L. Uvarova, V. Golimbet, M. Alfimova, N. Savvateeva, Y. Yurov, V. Trubnikov

    
  • ·P01.143 Characteristics of patients registered in databases of the clozapine monitoring system in Slovakia

    Página :358-358

    J. Pecenak, V. Novotny

    
  • ·P01.144 Distribution of serotonin transporter gene variants in human populations: A possible tool for understanding some aspects in psychiatric epidemiology

    Página :358-358

    S. Papiol, B. Gutiérrez, B. Arias, A. Rosa, B. Matín, L. Fañanás

    
  • ·P01.145 Amyloid beta peptide 1–40 influences a recognition site of hemicholinium-3 sensitive choline carriers and their proteolytic degradation

    Página :358-359

    Z. Krištofiková, H. Tejkalová

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.146 Interrater reliability of the clinical global impressions (CGI) scale in schizophrenia and depression: Results from a chart review reliability study

    Página :359-359

    M.J. Müller

    
  • ·P01.147 Analysis of suicides committed in podgorica during 1995–1999 period

    Página :359-359

    L. Injac, T. Bakovic, O. Vukovic

    
  • ·P01.148 Hypovitaminosis E in major depression

    Página :359-359

    A. Herran, M.T. de la Maza, M.T. Garcia-Unzueta, J.A. Amado, M.D. Fernandez, J.L. Vazquez-Barquero

    
  • ·P01.149 A comparative P300 study of young adult patients with depressive and depressive-delusional disorders

    Página :360-360

    I.S. Lebedeva, V.G. Kaleda, I.V. Oleichik

    
  • ·P01.150 Multidiscipline approach to prediction of schizophrenia in families

    Página :360-360

    V.A. Orlova, V.I. Trubnikov, T.D. Savina, I.S. Lebedeva, M.V. Alfimova, L.G. Uvarova, N.Yu. Savvateeva

    
  • ·P01.151 A controlled study comparing psychose hallucinatoire chronique” with two matched groups of schizophrenia is consistent with the independency of the two diagnosis

    Página :360-360

    C. Dubertret, P. Gorwood, J. Adés

    
  • ·P01.152 Cognitive performance in chronic alcoholism related to APO E genotype

    Página :360-361

    D. Bartrés-Faz, I.C. Clemente, M. Monrás, A. López-Alomar, P. Moral, M. Sánchez-Turet, C. Junqué

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.153 Schizotypy and handedness

    Página :361-361

    E. Cyhlarova, G.S. Claridge

    
  • ·P01.154 Alexithymia and chronic low back pain

    Página :361-361

    V. Faia, M. Sarchiapone, R. Bruni, M. Mazza, S. De Risio

    
  • ·P01.155 Psychiatric and endocrine aspects of anorexia nervosa

    Página :361-361

    E. Barbarino, M.A. Satta, M. Sarchiapone, S. De Risio

    
  • ·P01.156 Dissociation and body image in a sample of eating disorder patients

    Página :362-362

    G. Faragalli, M. Riccio, C. Giorgio, A. Mei, G. Pozzi, A. Ciocca, S. De Risio

    
  • ·P01.157 Dream as an index of psychic modifications

    Página :362-362

    A. Salone, G. Ruggeri, M. Sarchiapone, S. De Risio

    
  • ·P01.158 Short-term risperidone in anorexia nervosa: A case series

    Página :362-362

    M. Riccio, G. Pozzi, G. Conte, A. Ciocca, S. De Risio

    
  • ·P01.159 Trauma, memory and dissociation: 3 clinical experiences and a research proposal

    Página :362-363

    M. Mazza, M. Sarchiapone, V. Faia, P. Bria, S. De Risio

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.160 A comparative study of venlafaxine versus buspirone in outpatients with generalized anxiety disorder: Preliminary results

    Página :363-363

    L. Sevincok, H. Kaynak, F. Dereboy, A. Uslu, F. Baklac

    
  • ·P01.161 The man who lives in a bath tube. Chronic pain: A case report

    Página :363-363

    S. Uguz, Y.E. Evlice, I. Bilgen

    
  • ·P01.162 Psychiatric morbidity in the population immigrated from the South-Eastern part of Turkey: A randomised controlled study

    Página :363-363

    Y.E. Evlice, I. Bilgen, S. Uguz, M.L. Soylu, E. Yoldascan

    
  • ·P01.163 For how long can be expected a sustained improvement in schizophrenic patients treated with antipyschotics? A clinical experience with risperidone

    Página :363-364

    J. Gibert, J. Bobes, M. Gutiérrez

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.164 Depression and brain perfusion: A spect study

    Página :364-364

    R. Prikryl, E. Ceskova, A. Zourkova, V. Obrovska, J. Prasek

    
  • ·P01.165 Two cases of risperidone — induced tardive dyskinesia and a review of the literature

    Página :364-364

    L. Lykouras, R. Yannakis, P. Oulis, J. Hatzimanolis

    
  • ·P01.166 Marital status and eating disorders. Analysis of its relevance

    Página :364-364

    F. Fernández-Aranda, D. Bussolotti, R. Solano, A. Badia, L. Giménez, V. Turón, J. Vallejo

    
  • ·P01.167 Stage of change in anorexia and bulimia nervosa. Clinical and therapeutical implications

    Página :365-365

    F. Fernández-Aranda, V. Turón, I. Sánchez, M. Viñuales, M.J. Ramos, J. Vallejo, M. Katzman

    
  • ·P01.168 First major depressive episode among suicide attempters in Hungary

    Página :365-365

    J. Balázs, I. Bitter, Y. Lecrubier, N. Csiszér, J. Koszták

    
  • ·P01.169 Rehabilitation of refugees and forced migrants with social-stress disorders in Russia

    Página :365-365

    E.N. Prokudina, V.N. Prokudin, A.P. Muzychenko

    
  • ·P01.170 A factor analysis of signs and symptoms of the manic episode with Bech-Rafaelsen mania and melancholia scales

    Página :365-366

    A. Rossi, E. Daneluzzo, L. Arduini, O. Rinaldi, M. Di Domenico, C. Petruzzi

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.171 Comorbidity of bipolar mood disorders and unipolar mood disorders with personality disorders

    Página :366-366

    A. Rossi, M.G. Marinangeli

    
  • ·P01.172 Breath carbon monoxide increases during psychiatric hospitalisation

    Página :366-366

    D. Zullino, C. Bron, J. Besson, F. Borgeat

    
  • ·P01.173 Olanzapine improves social dysfunction in cluster B personality disorder

    Página :366-366

    D.F. Zullino, T. Häfliger, Ph. Quinche, M. Stigler

    
  • ·P01.174 Rapid remission of depression after carbamazepine augmentation of venlafaxine

    Página :367-367

    E. Ciusani, D.F. Zullino, C.B. Eap, Ph. Delacrausaz, P. Baumann

    
  • ·P01.175 Drug addiction and sexuality

    Página :367-367

    L. Di Furia, M.C. Forcella, N. Savani, S. Picello, F. Schifano

    
  • ·P01.176 A comparison of sexual offenders in custodial care and in penal institution

    Página :367-367

    S. Harsch, U. Jockusch, F. Keller

    
  • ·P01.177 White matter lesions and chronicity of depression

    Página :368-368

    A. Heiden, K. Kettenbach, P. Fischer, B. Schein, A. Bassalamah, R. Frey, T. Gulesserian, U. Itzlinger, S. Trattnig, H. Imhof, S. Kasper

    
  • ·P01.178 Phenelzine efficacy in refractory social phobia: A case series

    Página :368-368

    T.F. Aarre

    
  • ·P01.179 Psychodynamic factors affecting the compliance of psychiatric patient to medication

    Página :368-368

    I. Vartzopoulos, M. Angelopoulou, O. Gasparatou, G. Skourletos, E. Tzebelikos

    
  • ·P01.180 MRI in patients with social phobia

    Página :368-369

    N. Baková, J. Raboch, J. Obenberger, J. Leština

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P01.181 Thyroid axis alterations in psychoses

    Página :369-369

    D. Degner, V. Schlautmann, J. Kornhuber, E. Rüther, S. Bleich

    
  • ·P01.182 Some personal psychotherapeutic experience in a Moscow's district

    Página :369-369

    V. Skavych

    
  • ·P01.183 Atypical antipsychotic & rehabilitation program in a munchausen's syndrome (case report)

    Página :369-369

    M.T. Marques Pinto, L. Santos

    
  • ·P02.183 Lipid peroxidation after electroconvulsive therapy

    Página :371-371

    S. Bleich, D. Definer, S. Kropp, J. Pilz, E. Riither

    
  • ·P02.184 Saliva methanol values in alcohol withdrawal

    Página :371-371

    S. Bleich, E. Rfither, D. Definer, R. Sprung, J. Kornhuber

    
  • ·P02.185 The schizophrenic communication scale (SCD): A measure of schizophrenic dissociation

    Página :371-371

    N. Bazin, Y. Sarfati, C. Passerieux, M.C. Hardy-Bayle, C.H. de Versailles

    
  • ·P02.186 Anxiety and depression in family members of ICU patients: Ethical considerations regarding decision-making capacity

    Página :372-372

    F. Pochard, E. Azoulay, S. Chevret, I. Ferrand, J.F Dhainaut, B. Schlemmer

    
  • ·P02.187 Psychiatry for medical students in resource poor countries: a description of the curriculum at Malawi's medical school

    Página :372-372

    H. Herzig

    
  • ·P02.188 ¹H-Magnetic resonance spectroscopy at 3.0 tesla reveales reduced n-acetyl aspartate, choline and myo-inositol levels in depression

    Página :372-372

    R. Frey, S. Gruber, G. Ortwein-Swoboda, A. Heiden, V. Mlynarik, E. Moser, S. Kasper

    
  • ·P02.189 Measuring depression in schizophrenia: Relationship with negative symptoms

    Página :372-373

    V.P. Kontaxakis, B.J. Havaki-Kontaxaki, S.S. Stamouli, M.M. Margariti, C.T. Kollias, G.N. Christodoulou

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.190 Athens first-episode schizophrenia study: Efficacy of treatment with risperidone

    Página :373-373

    V.P. Kontaxakis, B.J. Havaki-Kontaxaki, S.S. Stamouli, G.N. Christodoulou

    
  • ·P02.191 Athens first episode schizophrenia study: Safety of treatment with risperidone

    Página :373-373

    V.P. Kontaxakis, B.J. Havaki-Kontaxaki, S.S. Stamouli, G.N. Christodoulou

    
  • ·P02.192 Suicidality and clinical symptoms in acute schizophrenic inpatients

    Página :373-374

    B.J. Havaki-Kontaxaki, V.P. Kontaxakis, M.M. Margariti, S.S. Stamouli, C.T. Kollias, G.N. Christodoulou

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.193 Apinarcotherapy — New progressive method of alcohol and drug addiction treatment

    Página :374-374

    I. Krivopalov-Moscvin

    
  • ·P02.194 Amantadine in patients with obsessive-compulsive disorder and borna disease virus-infection

    Página :374-374

    D.E. Dietrich, L. Bode, G. Von Rimon, T. Gödecke-Koch, D. Rada, H. Ludwig, H.M. Emrich

    
  • ·P02.195 Electrophysiological correlates of impaired components of word recognition in depression

    Página :374-374

    D.E. Dietrich, C. Waller, D. Rada, S. Johannes, H.M. Emrich, T.F. Müntel

    
  • ·P02.196 Inpatient vs. day treatment of alcoholics. Preliminary results of a controlled. Randomized study

    Página :374-375

    G. Weithmann, M. Hoffmann, H. Rothenbacher

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.197 Decoding of emotional facial expression in alcoholics

    Página :375-375

    B. Hermstein, H.C. Trauel

    
  • ·P02.198 Subject selection for the placebo- and comparator-controlled trials of neuroleptics in schizophrenia

    Página :375-375

    P. Mohr, P. Czobor

    
  • ·P02.199 Physical anhedonia and psychopathology: A study in a population of schizophrenic patients

    Página :375-375

    C.T. Kollias, V.P. Kontaxakis, E. Petridou, B.J. Havaki-Kontaxaki, S. Stamouli, D. Trichopoulos, G.N. Christodoulou

    
  • ·P02.200 Social anhedonia and psychopathology: A study in a population of schizophrenic patients

    Página :376-376

    C.T. Kollias, V.P. Kontaxakis, E. Petridou, B.J. Havaki-Kontaxaki, M. Margariti, D. Trichopoulos, G.N. Christodoulou

    
  • ·P02.201 Ad early response and remission of venlafaxine (ven: effexor®) and fluoxetine (flu: prozac®) in geriatric outpatients

    Página :376-376

    A.F. Schatzberg, M. Cantillon

    
  • ·P02.202 Remission rates with different dosages of ven (ven) versus ssris and PBO (PBO) in major depressive disorder

    Página :376-376

    R. Entsuah

    
  • ·P02.203 Response and remission with venlafaxine, SSRIs, or placebo in different subpopulations with major depression

    Página :376-377

    R. Entsuah

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.204 Venlafaxine demonstrates superior sustained remission compared with ssris or placebo

    Página :377-377

    R. Entsuah

    
  • ·P02.205 From classical neurology to neurology of self. The reception of history of neurology and its systematic position in the work of O.W. Sacks

    Página :377-377

    E.H. Hische

    
  • ·P02.206 Electrophysiological correlates of changed cognition in patients with obsessive-compulsive disorder

    Página :377-377

    D. Radar, D.E. Dietrichr, S. Johannes, H.M. Enuich, T.F. Münte

    
  • ·P02.207 Bone mineral density in adult with history of treatment of anorexia nervosa

    Página :377-377

    G. Jagielska, T. Wolanczyk, C. Tomaszewicz-Libudzic, J. Komender, J. Przedlackil, K. Ostrowski, E. Musial, A. Dwornik

    
  • ·P02.208 Anxiety, hyperventilation and cerebral hypoxia: is aerobic exercise good for your brain?

    Página :378-378

    L. Dratcu

    
  • ·P02.209 Serial sexual offenders: brain's predisposition

    Página :378-378

    O.A. bukhanovskaya

    
  • ·P02.210 The menstrual cycle phase and the therapeutic response in schizophrenic women

    Página :378-378

    I. Vanǔrova, A. Yamamotová

    
  • ·P02.211 Burnout among hospital and community based mental health staff

    Página :378-379

    V. Bozikasl, V. Kioseogloul, M. Palialial, I. Nimatoudis, A. Iakovides, I. Diakoyanni-Tarlatzisl, A. Karavatos, G. Kaprinis

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.212 Effects of child homicide in the quality of maternal care: A case report

    Página :379-379

    I. Savvidou, V. Bozikas, A. Pitsavas, A. Karavatos

    
  • ·P02.213 Topiramate in the treatment of mania

    Página :379-379

    V. Bozikas, P. Petrikis, A. Karavatos

    
  • ·P02.214 Therapeutic efficacy and metabolic peculiarities in patients with depressive disorders under tianeptine (TIA) and sertraline (SER) treatment

    Página :379-379

    N. Maximova, E. Misionzhnik, O. Vertogradova, M. Usbekov

    
  • ·P02.215 Adolescents and suicide attempts

    Página :379-380

    D. Anagnostopoulos, H. Lazaratou, I. Amvraziadou, G. Vaslamatzis

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.216 Acute admissions of foreign born people in a closed psychiatric ward

    Página :380-380

    M. Ruiz Ruiz, J.M. Pena-Andrew, J. Torres Ojeda, F. Gonzalez Escalante, A. Rodriguez Rosado, P. Cano Dominguez

    
  • ·P02.217 Clinical course of depression and platelet serotonin uptake

    Página :380-380

    Z. Fišar, I. Paclt

    
  • ·P02.218 Cyamemazine: A revision of its therapeutical anxiolytic profile based on its recently described anti-serotoninergic activity

    Página :380-380

    F. Radat, R. Garay, F. d'Alché-Birée, M. Dib

    
  • ·P02.219 Energy stores in alzheimer's disease (AD)

    Página :380-381

    F. Abalan

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.220 Transcultural adaptation and validation of the quality of life questionnaire

    Página :381-381

    E. Libigerova, H. Müllerová, M. Prouzová, M. Blazkova, P. Matejkova, J. Krepela, J. Mrozek

    
  • ·P02.221 Prevalence of depression (short version of depression questionnaire): Sociologic issues

    Página :381-381

    N.A. Kornetov, E.D. Schastny

    
  • ·P02.222 Suicidal behavior in adolescence in Eestern Siberia

    Página :381-381

    A.N. Kometov, N.A. Kometov

    
  • ·P02.223 Phenomenological aspects of dissociative experiences in depressive and substance abuse pathology

    Página :381-382

    L. Severino, M.L. Figueira

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.224 Antidepressant evoked alterations of transmembrane cell signalling

    Página :382-382

    H. Kovářú, A. Fišerová, F. Kovářú, Z. Fišar, V. Lisá, I. Malbohan

    
  • ·P02.225 Wisconsin card sorting test performance in subclinical obsessive-compulsive subjects: Relation to symptom dimensions

    Página :382-382

    D. Mataix-Cols, M. Aleu, C. Junqué, M. Sanchez-Turet

    
  • ·P02.226 Psychotropic treatment and weight gain

    Página :382-382

    S. Stella, A. Ravera, F. De Santis, C. Persichella, N. Gosio, C. Rizzoli

    
  • ·P02.227 Comparison of the coronary heart disease risk factor profile of risperidone vs olanzapine treated patients

    Página :382-383

    R.H. Bouchard, J. Villeneuve, N. Alméras, I. Simoneau, M.F. Demers, C. Cadrin, M.A. Roy, J.P. Mortard, J.P. Despres

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.228 Sexual dysfunction burden in a 24-week study of SSRIS in depressed patients

    Página :383-383

    L. Ekselius, H. Agren, A. Aberg-Wistedt

    
  • ·P02.229 A placebo-controlled study of sertraline in generalized social phobia

    Página :383-383

    M. Van Ameringen, R. Swinson, J.R. Walker, R.M. Lane

    
  • ·P02.230 Sertraline versus imipramine in non-melancholic depression

    Página :383-384

    E. Baca, M. Gonzalez de Chavez, M. Garcia-Toro, F. Perez-Arnau, A. Rives, B. Penasa, S. Olivaros, J. Espejo, A. Porras, R. Lane

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.231 24-week prevention of relapse of generalized social phobia study in responders to 20-weeks of sertraline treatment

    Página :384-384

    M. Van Ameringen, R. Swinson, J.R. Walker, R.M. Lane

    
  • ·P02.232 Impact of residual symptoms on outcomes in GAD: Evidence from placebo-controlled trials of venlafaxine er

    Página :384-384

    J.G.C. Rasmussen, D. Hacken, P. Meoni, C. White

    
  • ·P02.233 Influence of selected ssri on activity of cytochrome p450 2di and arylamine N-etyltransfearase in wistar rats

    Página :384-385

    Z. Justinova, K. Nerusilova, E. Hadasova, M. Tomandloval

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.234 Biphasic effects of cannabinoids on leukocyte phagocytosis in mice

    Página :385-385

    J. Vinklerova, J. Nováková, A. Šulcová

    
  • ·P02.235 Biological markers of the hyperkinetic syndrome in children of age 6 to 10 years

    Página :385-385

    I. Paclt, P. Uhlíková, J. Koudelová, P. Bauer, M. Vaněčková, V. Mat'oška, A. Bóday, Z. Saidl

    
  • ·P02.236 ECG mapping with a view to ischemic changes of a myocardium in patients with a panic disorder

    Página :385-385

    I. Paclt, K. Pišvejcová, J. Slaviček, O. Kittnar

    
  • ·P02.237 Mirtazapine: A quick and effective treatment in patients with depression-related anxiety symptoms

    Página :385-386

    J. Ladner, A.A. Nimmerrichter

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.238 Psychiatric disorders and psychiatric treatment in ecstasy users compared to users of other illicit drugs and controls in a representative sample of young germans

    Página :386-386

    C.G. Schütz, R. Lieb, H. Pfister, U. Wittchen

    
  • ·P02.239 Family study of suicidal behaviour in bipolar disorder

    Página :386-386

    P. Cavazzoni, B. Ahrens, A. Berghöfer, A. Duffy, E. Grof, B. Mfller-Oerlinghausen, P. Zvolský, P. Grof, M. Alda

    
  • ·P02.240 Are conventional antipsychotics the only option for the treatment of first episode schizophrenia?

    Página :386-386

    M.Yu. Popov

    
  • ·P02.241 The ideological dimensions of the burnout syndrome in psychiatric institutions

    Página :386-387

    E. Lozinskaya, V.M. Bekhtererev

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.242 Delivering information to schizophrenic patients: A review of available studies

    Página :387-387

    D. Gerard, N. Bazin, P. Nuss, P. Fremont, M. Ferreri

    
  • ·P02.243 Schizophrenia and parkinsonism vs. lateralization

    Página :387-387

    D. Marinkovic

    
  • ·P02.244 Neuropsychological impairments and symptoms of schizophrenia

    Página :387-387

    S. Klingberg, R. Gutjahr, A. Wittorf, G. Wiedemann

    
  • ·P02.245 External validity of randomised clinical trials (RCT'S): Is there a selection bias in psychotherapy treatment studies of schizophrenia?

    Página :387-388

    G. Wiedemann, S. Klingberg, A. Wittorf, A. Fischer, G. Buchkremer

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.246 The effects of restrictive diet in gluten kasein sensitive autistic persons — (pilot study)

    Página :388-388

    L. Aneta, S. Milijana, L. Dragan, M. Ivona

    
  • ·P02.247 Quality of life in a danish sample of schizophrenic inpatients

    Página :388-388

    V. Noerholm

    
  • ·P02.248 Major depression and psychological well-being in the general danish population

    Página :388-388

    L. Raabæk Olsen, V. Norholm, N.-A. Rasmussen, T. Watt, M. Grønvold, J. Bjømer, P. Bech

    
  • ·P02.249 Factors associated with therapeutic effect of risperidone on psychopathology and working memory in schizophrenic patients

    Página :389-389

    A. Borkowska, A. Kućma, J.K. Rybakowski

    
  • ·P02.250 Factors predicting depression among male and female in an Arab community

    Página :389-389

    R. Ghubash, T.K. Daradkeh, M.T. Abou-Saleh

    
  • ·P02.251 Depression in patients with fabry disease

    Página :389-389

    S.V Kopishinskaya, A.V Gustov

    
  • ·P02.252 Neurobehavioural study of long-term peroral administration of dehydroepiandrosterone in old rats

    Página :389-390

    H. Tejkalová, R. Hampj, M. Bičíková, P. Hušek, Z. Krištofikovál, O. Benešovál

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.253 Personality in patients with chronic fatigue syndrome compared to depressed patients

    Página :390-390

    M. Schlöǵelhofer, U. Willinger, U. Itzlinger, Ch. Wolf, U. Bailer, H.N. Aschauer

    
  • ·P02.254 TPQ, in functional dysphonia

    Página :390-390

    U. Willinger, H.N. Aschauer

    
  • ·P02.255 The relationship between alzheimer's disease, early onset and late-onset depression in the elderly assessed in a family study

    Página :390-390

    R. Heun, A. Papassotiropoulos, F. Jessen, W. Maier, J.C.S. Breitner

    
  • ·P02.256 Sleep in OCD: A correlational study

    Página :390-391

    A. Matos-Pires, F. Cavaglia, A. Atalaia, E. Lara, F. Arriagal

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.257 Clinical assessment of sleep in OCD: A comparative study

    Página :391-391

    A. Matos-Pires, F. Cavaglia, E. Lara, F. Arriaga

    
  • ·P02.258 Psychiatry of extremal situations

    Página :391-391

    V.N. Krasnov

    
  • ·P02.259 Development of psychiatric care network in Russia

    Página :391-391

    B.A. Kazakovtsev

    
  • ·P02.260 Delivering aid to the victims of man-caused disasters and acts of terrorism

    Página :392-392

    A.O. Bukhanovsky

    
  • ·P02.261 Long-term trends of symptoms and of disability in schizophrenia and related disorders

    Página :392-392

    K. Ganev, G. Onchev

    
  • ·P02.262 Prevalence of personality disorders among alcoholic patients

    Página :392-392

    B. Bodnár, E. Pálová, I. Lukácsová, L. Medvecká, M. Kovaničová, K. Kubašovská

    
  • ·P02.263 Do amitriptyline and citalopram differ in the effect on membrane characteristics of rat cardiomyocytes in culture?

    Página :392-393

    J. Hamplová, J. Krůšek, I. Paclt, J. Slaviček, V. Lisá

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.264 Antidepressant therapy and heart electric field: Quantitative aspects

    Página :393-393

    I. Paclt, J. Slavíček, A. Dohnalová, O. Kittnar, K. Pišvejcová, E. Kitzlerová

    
  • ·P02.265 Efficacy and tolerability of reboxetine used by elderly depressed patients

    Página :393-393

    J. de la Gándara, P. Such

    
  • ·P02.266 Why is length of stay in psychiatric clinics exponentially distributed? An analysis of contributing factors

    Página :393-393

    A. Stevens, K. Hammer, G. Buchkremer

    
  • ·P02.267 Unimpaired perception, but impaired working memory and motor retardation in borderline patients

    Página :393-394

    A. Stevens, M. Nickola, M. Burkhardt, N. Rosellen

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.269 Attitudes and perceptions related to drug abuse in a sample of Greek users, ex-users and professional workers

    Página :394-394

    J. Liappas, E. Mellos, P. Papavasiliou, G.N. Christodoulou

    
  • ·P02.270 Attitudes and perceptions of professional workers facing drug addiction problems

    Página :394-394

    J. Liappas, E. Mellos, P. Papavasiliou, G.N. Christodoulou

    
  • ·P02.271 Pharmacokinetic drug interaction potential of risperidone as assessed by the dextromethorphan, the caffeine and the mephenytoin test

    Página :394-395

    C.B. Eap, G. Bondolfi, D. Zullino, C. Bryois, M. Fuciec, L. Savary, M. Jonzier-Perey, P. Baumann

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.272 Follow up study of atypical antipsychotics for patients with psychiatric disorders and intellectual disability

    Página :395-395

    M. Vanstaelen, N. Bouras, G. Holt, J. Martin

    
  • ·P02.273 10 year follow up of a scottish schizophrenia cohort

    Página :395-395

    M.G. Livingston, R. Ward, M. McLaughlin

    
  • ·P02.274 Training model in psychotherapy for general physicians

    Página :395-395

    J. Beran

    
  • ·P02.275 Weight gain with antipsychotic medication — two years follow up study

    Página :395-395

    V. Lívia, K. Soña, K. Mariana

    
  • ·P02.276 The impact of huntington's disease on caregivers: The czech experience

    Página :395-396

    J. Roth, T. Uhrová, P. Doubek, M. Preiss, J. Židovská

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.277 Autonomic neurocardiac regulation (ANR) in patients with major depression and effects of antidepressive treatment with reboxetine

    Página :396-396

    M.W. Agelink, B. Baumann, W. Lemmer, E. Klieser

    
  • ·P02.278 Effects of sildenafil (viagra®) on cardiovascular autonomic function (CAF) in man: Preliminary results

    Página :396-396

    M.W. Agelink, T. Majewski, T. Schmitz, M. Mück-Weymann

    
  • ·P02.279 The cardiovascular safety profile of amisulpride in man: Results of an open clinical study

    Página :397-397

    M.W. Agelink, F.X. Eich, E. Klieser

    
  • ·P02.280 Testosterone, ageing and coital activity

    Página :397-397

    S. Pietrucha, J. Raboch, J. Raboch

    
  • ·P02.281 Functional magnetic resonance imaging of reaction to food presentation in anorexia nervosa

    Página :397-397

    U. Rudolf, P. Hana, O. Jiři, K. Jan

    
  • ·P02.282 The prevalence of depression in the Czech Republic

    Página :397-398

    D. Vanek, J. Raboch, J. Vanek

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.283 The relationship between aspects of trait impulsivity and impulsive suicidal behavior

    Página :398-398

    B. Ripke

    
  • ·P02.284 Transgenic mice overexpressing brain human amyloid precursor protein show an age-dependent cognitive impairment in the morris water maze

    Página :398-398

    M. Ort, M. Koistinaho, R. Vondrous, J.M. Cimadevilla, J. Koistinaho, L.S. Higgins, J. Bures

    
  • ·P02.285 Could anorexia be considered as an addiction?

    Página :399-399

    F. Levy, J. Behm, J.M. Pinoit

    
  • ·P02.286 Agitation and aggressiveness among French elderly resident

    Página :399-399

    J.-M. Leger, R. Moulias, P.H. Robert, B. Vellas, M. Micas, K. Djaballah

    
  • ·P02.287 The psychophysic relaxation and neuroticism in the children with cerebral palsy

    Página :399-399

    I. Slaviček

    
  • ·P02.288 Biological factors in female sexual development

    Página :399-399

    J. Raboch, J. Hořejšsi, J. Raboch

    
  • ·P02.289 Study of the cyclothymic temperament scale in controls and relatives of mood disorder patients [depressive and bipolar]

    Página :399-400

    P. Chiaroni, E. Hantouche, J. Gouvernet, J.-M. Azorin

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.290 The nicotine dependence in inpatients with schizophrenia and schizoaffective disorder

    Página :400-400

    P. Fridrich, T. Morcinek, M. Pošmurová, I. Zukov

    
  • ·P02.291 Cholesterol concentrations in high and low women suicide attempters

    Página :400-400

    J. Vevera, I. Žukov, T. Morcinek

    
  • ·P02.292 Tradition, clinical needs and economy: Their effects on the development of neuro-psychopharmacology: Czech and Slovak experience

    Página :401-401

    O. Vinat

    
  • ·P02.293 Navigation and it's idiothetic and allothetic components in healthy young humans

    Página :401-401

    K. Stepankova, A.A. Fenton, J. Bures, M. Kalina, V.D. Bohbot

    
  • ·P02.294 Post-traumatic stress disorder in a student population several years after bomb attack

    Página :401-401

    J. De Mol, D. Lecompte, I. Pelc

    
  • ·P02.295 Agression and PTSD: Medicolegal evaluation

    Página :401-402

    J. De Mol, D. Lecompte, I. Pelc

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.296 Observation of an embarassing” effect during the initial phase of treatment with olanzapine on the subjective experience in three longstay schizophrenic patients with promiment negative symptoms

    Página :402-402

    C.V. de Blécourt, P.J.S. Michielsen, W.M.A. Verhoeven

    
  • ·P02.297 Sildenafil citrate (viagra) treatment of sexual dysfunction in schizophrenic patient

    Página :402-402

    I. Reznik, R. Benatov, Z. Zemishlany

    
  • ·P02.298 Switching from conventional to new atipical antipsychotics in schizophrenic patients: A study on patient's satisfaction

    Página :402-402

    G. Bartkó, L. Simon, T. Tüske, E. Linka, H. Váradi, T. Szabó

    
  • ·P02.299 Early onset of schizophrenia and efficacy of risperidone

    Página :402-403

    I. Drtíková

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.300 Gender differences in psychiatric admissions: The influence of culture and social psychiatry

    Página :403-403

    Y. Amin, E. Hamdi

    
  • ·P02.301 Life quality in a group of elderly people who are non-sufficient, and non institutionalized

    Página :403-403

    S. Fassino, G.Abbate Daga, P. Leombruni, A. Brustolin, I. Garzaro, F. Amianto, G. Lazzarini, F. Fabris, G.G. Rovera

    
  • ·P02.302 Bulimic family dynamics: Temperament and character dynamics

    Página :403-404

    S. Fassino, G.Abbate Daga, P. Leombruni, F. Amianto, M. Levi, F. deDominicis, G.G. Rovera

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.303 Study of psychotic disorders with artificial neural networks

    Página :404-404

    J.V. Rodado, M.J. Rodado, J.M. Chamizo, F. Iborra, B. Ledesma, J. Mora, D. Barcia

    
  • ·P02.304 Predicting outcome of first episodes of schizophrenia

    Página :404-404

    M.J. Rodado, J.V. Rodado, J. Hernandez

    
  • ·P02.305 A comparison of English and Italian drug legislation, their policies of intervention and any consequences upon stress and burnout at work

    Página :404-405

    M. Barbo

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.306 Smooth pursuit eye movement (SPEM) in bulimia nervosa

    Página :405-405

    K. Hynek, M. Anders

    
  • ·P02.307 Alexithymia correction at hypertension patients with affective disoders

    Página :405-405

    B.G. Goldin, O.M. Gilinskaya, M.V. Cherkalina

    
  • ·P02.308 Psychiatric co-morbidity among amphetamine users: Relations to amphetamine-induced psychosis

    Página :405-405

    C.-K. Chen, S.-K. Lin, P. Sham, D. Ball, E.-W. Loh, R. Murray

    
  • ·P02.309 Psychiatric morbidity among juvenile drug offenders

    Página :405-406

    C.-F. Yen, M.-Y. Chong, Y.-H. Liu

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.310 Working with schizophrenic people: Informations to their families

    Página :406-406

    R. Bosio, S. Salomoni

    
  • ·P02.311 Coping strategies in relatives of patients with schizophrenia

    Página :406-406

    F. Osterman, M.Z. Dernovšek, R. Tavèar, V. Novak-Grubiè

    
  • ·P02.312 Violence and crime: Psychiatric approach

    Página :406-406

    G.F. Eleta, C.L. Gatti, R.A.Sotelo Largo

    
  • ·P02.313 Forensic psychiatric study of sexual abuse

    Página :406-407

    J.C. Romi, L.Garcia Samartino, G.F. Eleta, C.L. Gatti, M. Gaziglia

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.314 The wessex recent inpatient suicide study: 1. Case-control study of 234 recently discharged psychiatric inpatient suicides

    Página :407-407

    D.S. Baldwin, J.M.A. Sinclair, E.E. King

    
  • ·P02.315 The wessex recent inpatient study: 2. Case-control study of 59 inpatient suicides

    Página :407-407

    J.M.A. Sinclair, D.S. Baldwin, E.A. King

    
  • ·P02.316 Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (efeso study)

    Página :407-407

    J.C. Gomez, J.A. Sacristan, E. Edgell, M.Gonzalez de Chavez, S. Gavart

    
  • ·P02.317 Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia

    Página :408-408

    E.T. Edgell, W.Scott Andersen, B.M. Johnstone, B. Dulisse, D. Revicki, A. Breier, S. Gavart

    
  • ·P02.318 Global index of safety (GIS): A new instrument to assess drug safety: Application to a prospective pharmacoepidemiological study (EFESO)

    Página :408-408

    J.A. Sacristán, J.C. Gómez, X. Badia, P. Kind, S. Gavart

    
  • ·P02.319 Antipsychotic treatment, adverse events and health-related quality of life

    Página :408-408

    X. Badia, A. Casado, J.A. Sacristán, J.C. Gómez, K.J. Gregor, S. Gavart

    
  • ·P02.320 Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study)

    Página :409-409

    J.C. Gomez, J.A. Sacristan, P.R. Carrasco, E. Alvarez, J. Bobes, F. Cañas, J. Gascon, J. Gibert, M. Gutierrez

    
  • ·P02.321 Occurrence of CYP2D6 gene duplication in Hong Kong Chinese

    Página :409-409

    L.Y. Chow, M. Garcia-Barceló, K.L. Lam, H.F.K. Chiu, Y.K. Wing, M.M.Y. Waye

    
  • ·P02.322 Effectiveness of biological and non biological treatments in schizophrenia

    Página :409-409

    P.L. Marconi, L. Fonticoli

    
  • ·P02.323 Autonomic disturbance in malignant catatonia

    Página :409-410

    A. Ruiz, Ma.M. Laya, R. Coronas, C. Doménech, G. García, N. García, S. Escoté

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.324 Diagnosing psychiatric comorbidity in a drug-addiction unit

    Página :410-410

    M. Astals, D. Serrano, G. Pérez, R. Marti-Santos, C. Castillo, M. Torrens

    
  • ·P02.325 Residential care in Andalusia and London: A comparison

    Página :410-410

    N. Trieman, F. Torres-Gonzalez, C. Rickard, J.C. Maestro, M. Laviana, B. Moreno-Küstner

    
  • ·P02.326 Standardised description of psychiatric care. The need to place every service in its specific context

    Página :410-410

    C. Munizza, G. Tibaldi

    
  • ·P02.327 The influence of the computerized management system in the philosophy of the department of mental health of North East Italy

    Página :410-411

    M. Del Pin, M. Marin, V. Giorgio

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.328 The big five inventory: The French version

    Página :411-411

    O. Plaisant, O.P. John, S. Srivastava, G.A. Mendelsohn

    
  • ·P02.329 Atypical versus conventional antipsychotic medication: Impact on subjective quality of life of patients with schizophrenia or related disorders

    Página :411-411

    R. Tempier, N. Pawliuk

    
  • ·P02.330 Cost of a manic episode in bipolar disorder: A French study

    Página :411-411

    J.-P. Olié, E. Levy, J. Spiesser

    
  • ·P02.331 Medication management of a manic episode in bipolar disorder: A French study

    Página :411-412

    J.-P. Olié, E. Levy, P. Carita

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.332 Schizotypy and hypomania as correlates of creative achievement

    Página :412-412

    B.T.C. Miller

    
  • ·P02.333 Switching to amisulpride: Findings from a retrospective questionnaire

    Página :412-412

    J.P. Chabannes, A. Giudicelli, S. Farah, D. Gerard

    
  • ·P02.334 The effect of amisulpride on affective and social negative syndromes in schizophrenia

    Página :412-412

    A. Braconnier, P. Lessieur, P. Martin, K. Djaballah, D.A. Gerard

    
  • ·P02.335 Pattern of prescription of antipsychotic drugs in psychiatric departments

    Página :412-413

    F. Rouillon, P. Nuss, K. Djaballah, D.A. Gerard

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.336 Assessing the impact of delivering information to schiizophrenic patients: The soleduc program

    Página :413-413

    P. Nuss, D.A. Gerard, M. Ferreri

    
  • ·P02.337 Use os atypical antipsychotics in the emergency department of psichiatry

    Página :413-413

    A. D'ambrosio, F. Laura, R. Petrone

    
  • ·P03.338 Experiences with the open-door-system in a adult inpatient psychiatric unit in a German general hospital

    Página :413-414

    A. Dippel, I. Munk, K. Demisch

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.339 Reliability and validity of the psychosocial aptitude and efficacy rating scales (PARS) in a schizophrenic patient sample

    Página :414-414

    G. Darcourt, P. Martin, D. Lethuaire, C. Ferretti, D. Gérard

    
  • ·P02.340 Predictive factors for mental health in patients admitted for ischaemic cardiopathy in auniversity hospital in the south of Spain

    Página :414-414

    J. Elorza, I. Ramos, F. Fernandez-Palacin, I. Failde

    
  • ·P02.341 Depressive syndrome in schizophrenia — A psychosocial aspect

    Página :414-414

    Lj. Leposavić, G. Nikolić-Balkoski, J. Barišić, Z. Barac, S. Milovanović

    
  • ·P02.342 Six-month outcome of electroconvulsive therapy and repetitive transcranial magnetic stimulation treatment in severely depressed patients

    Página :414-415

    P.N. Dannon, L. Grunhaus, O.T. Dolberg, S. Schreiber

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.343 Electroconvulsive therapy is effective in the treatment of patients who failed to respond to a course of repetitive transcranial magnetic stimulation

    Página :415-415

    P.N. Dannon, R. Amiaz, S. Schreiber, L. Grunhaus

    
  • ·P02.344 Repretitive transcrainial magnetic stimulation is effective as the first time in the treatment of relapse of depression

    Página :415-415

    P.N. Dannon, S. Schreiber, O.T. Dolberg, L. Grunhaus

    
  • ·P02.345 Literacy rate, gross domestic product and suicide rate in 33 European countries

    Página :415-415

    A. Marušic, M. Khan, A. Farmer

    
  • ·P02.346 Correlation between suicide risk, time spent in prison and vulnerability profile of people in confinement

    Página :415-416

    P. Frottier, K. Ritter, S. Frühwald, F. König, P. Bauer

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.347 Deprivation versus importation: A model explaining the increase of suicide rates in custody

    Página :416-416

    P. Frottier, K. Ritter, S. Frühwald, S. Lehr, P. Bauer

    
  • ·P02.348 Psychopathology in patients with treated Wilson's disease

    Página :416-416

    K. Portala, L. Ekselius, L. von Knorring

    
  • ·P02.349 What are the skills required for general practice and paediatrics as FAS as the psychopathology of children and adolescents is concerned?

    Página :416-416

    L. Philippe, E. Lemonnier, J. Jouquan, A. Lazartigues

    
  • ·P02.350 The assessment and treatment team: A new approach to mental health services in conventry

    Página :416-417

    N.M.J. Burley, S.J. Tripp, A.Ashley Smith

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.351 Al Ain community survey of psychiatric morbidity III: The natural history of psychopathology and the utilization rate of psychiatric services in Al Ain

    Página :417-417

    T.K. Daradkeh, R. Ghubash, M.T. Abou-Saleh

    
  • ·P02.352 Depression and anxiety in coronary artery bypass grafting patients

    Página :417-417

    J. Rymaszewska, A. Kiejna

    
  • ·P02.353 Relationship between cognitive function and interpersonal problem-solving skills in schizophrenic patients compared to healthy subjects

    Página :417-418

    Ph. Huguelet, A. Zanello

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.354 Annoucement of diagnosis of schizophrenia

    Página :418-418

    J.C. Seznec, G. Saba, L. Stamatiadis, A. Lefort, J.F. Rocamora, D. Januel

    
  • ·P02.355 Comedication in psychiatric illneses

    Página :418-418

    L.K. Montane Jaime, M. Ackenheil

    
  • ·P02.356 Mental health support for war refugees

    Página :418-418

    W. Rutz, L. Urbina, H. Wahlberg

    
  • ·P02.357 Comparison of the treatment outcome measures in panic disorder

    Página :418-419

    V. Starcevic, G. Bogojevic, M. Latas, D. Kolar

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.358 Mid life women, depression and somatisation

    Página :419-419

    M.M.M.P. Van Moffaert

    
  • ·P02.359 Tianeptine for the treatment of major depressive episode: A double-blind study versus fluoxetine

    Página :419-419

    F. Faltus, V. Novotný, J. Raboch, I. Žucha

    
  • ·P02.360 Differences in echogenicity of substantia nigra in patients with different subtypes of the schizophrenic spectrum

    Página :419-420

    B. Jabs, D. Berg, U. Merschdorf, B. Pfuhlmann, A.J. Bartsch, K.V. Toyka, H. Beckmann, G. Becker

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.361 P300 amplitude over temporal regions in schizophrenia: An investigation using Japanese subjects

    Página :420-420

    A. Iwanami, N. Kato, K. Kasai, S. Kamio, S.-i. Furukawa, M. Fukuda, K. Nakagome, Y. Okajima, H. Isono, K. Kamijima

    
  • ·P02.362 Interventions of medico-psychological emergency teams in France

    Página :420-420

    P. Louville

    
  • ·P02.363 GHB treatment of alcohol and drug addiction

    Página :420-420

    L. Tarricone

    
  • ·P02.364 Efficacy of antidepressants in the treatment of severe depression

    Página :420-421

    U. Bailer, H.N. Aschauer, S. Kasper

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P02.365 Vascular dementia the most frequent cause of dementia: Four year outcome in Kosice

    Página :421-421

    H.M. Shahpesandy, M. Medvecky, E. Palova, S. Kitkova, M. Kafkova, J. Vancikova, M. Murcko, I. Lukacsova

    
  • ·P03.366 Predictors of good prognosis in patients with schizophreniform disorders

    Página :423-423

    I. Iancu, E. Lepkifker, P.N. Dannon

    
  • ·P03.367 Violence in psychiatry. A study on an accreditation program

    Página :423-423

    J.G. Rohmer, B. Kastler

    
  • ·P03.368 Mental health of students. Four years of functionning of specialized institution in Strasbourg

    Página :423-423

    M. Patris, B. Piret

    
  • ·P03.369 Generalized anxiety disorder in dysfunctional families

    Página :423-423

    L. Ben-Noun

    
  • ·P03.370 Effect of axis I comorbidity on bipolar II age at onset

    Página :424-424

    F. Benazzi

    
  • ·P03.371 Psychotic depression: Bipolar II and unipolar

    Página :424-424

    F. Benazzi

    
  • ·P03.372 From amisulpride to rehabilitation

    Página :424-424

    I. Vlokh, S. Mikhnyak, Y. Gorodylovsky

    
  • ·P03.373 Experience of Stablon (tianeptine) administration in neurotic states with anxiety

    Página :424-425

    I. Vlokh, B. Kulyk, R. Bilobryvka

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.374 Visuo-spatial functions in the schizophrenic spectrum

    Página :425-425

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    
  • ·P03.375 Therapy treatment-resistant depressions

    Página :425-425

    G. Mazo

    
  • ·P03.376 To philosophic statement of a question about mental health in Russian culture

    Página :425-425

    V. Skavych

    
  • ·P03.377 Russian psychoanalysis must correct the Freud's mistake

    Página :425-426

    V. Skavych

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.378 Reboxetine in negative symptoms of schizophrenia

    Página :426-426

    E. Aragüés, P. Malo, L. Pacheco, M. Etxebeste, M. Aragüés, M. Prieto

    
  • ·P03.379 Suicide in Harghita county, 1991–1999. Epidemiological research

    Página :426-426

    A. Veress, G. Vadas

    
  • ·P03.380 Towards systematization of psychotic disorders with sexual content in schizophrenia

    Página :426-426

    K. Danielyan, A.Danielyan Susanna

    
  • ·P03.381 Intentionality and ERPs in the three dimensions of schizophrenia

    Página :426-426

    M. Bertelli, G. La Malfa, V. Pieroni, M. Conte, P. Cabras

    
  • ·P03.382 Coercion and ward resources

    Página :427-427

    K. Rosenberg Andersen

    
  • ·P03.383 Organic asthenic disorder and successful education of preliminary schoolchildren

    Página :427-427

    N. Butorina, G. Butorin

    
  • ·P03.384 About conception of dissocial development in childhood

    Página :427-427

    G. Butorin

    
  • ·P03.385 Depressive disorders at adolescents within penitentionary maladjustment

    Página :427-428

    E. Krivulin, S. Betskov

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.386 Heboid syndrome of residual-organic genesis at preliminary pupils

    Página :428-428

    T. Kolesnichenko

    
  • ·P03.387 Dynamic of psuchomotor disorders of residual organic genesis

    Página :428-428

    E. Malinina

    
  • ·P03.388 Rsychophysical maldevelopment as the reason of deviant behavior in childhood

    Página :428-428

    L. Rychkova

    
  • ·P03.389 Individual social and labour long-term prognosis in attack form schzophrenia

    Página :428-429

    L. Anachkina

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.390 Family therapy in substance abuse disorders

    Página :429-429

    C. Bressi, G. Invernizzi

    
  • ·P03.391 Prevalence and severity of psychiatric co-morbidity in nicotine dependence

    Página :429-429

    M. Riglietta, M. Campana, L. Musitelli, L. Tidone

    
  • ·P03.392 Mental disturbances in persons exposed to radiation after chernobyl NPP accident

    Página :429-429

    I.V. Zdesenko

    
  • ·P03.393 Changings in psychopathology of schizophrenic patients during the NATO intervention in Yugoslavia

    Página :429-430

    G. Nikolić-Balkoski, Lj. Leposavić, J. Barišić-Rojnić, D. Duišin

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.394 The difference of reduction posttraumatic stress disorders treated by standard and retard forms of Xanax

    Página :430-430

    V. Voloshin, L. Kim

    
  • ·P03.395 Therapy of depressive disorders with tianeptin and sertralin in patients with hypertension and ischemic heart disease

    Página :430-430

    K.V. Tarasova, V.N. Krasnov, E.A. Nesterova, I.A. Sadulaeva, T.V. Dovzhenko

    
  • ·P03.396 School for psychophysical self-regulation of diabetes mellitus patients

    Página :430-430

    I. Shybaeva

    
  • ·P03.397 Effect of risperidon on autonomic regulation in patients of affective disorders in period between the relapses

    Página :430-431

    T.S. Melnikova, E.G. Kostyukova, G.M. Granyonov

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.398 Heart rate variability following transcranial magnetic stimulation in major depression

    Página :431-431

    S. Kapiletti, E. Tsukarzi, S. Mosolov

    
  • ·P03.399 The structure of psychosis among patients with contemporary forms of organic damage of brain

    Página :431-431

    E. Maxoutova, E. Jeleznova, L. Socolova, A. Zemlyanaya

    
  • ·P03.400 Xanax-retard in the ambulant treatment of psychogenic depression

    Página :431-431

    V. Makeev

    
  • ·P03.401 Moclobemide and psychodynamic psychotherapy in complex treatment of social phobia

    Página :431-432

    A. Litvinov, L. Gorobetz, V. Vjatkina

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.402 Sexual dysfunctions and endocrynous system in chernobyl patients and those with the CNS's organic deficiencies

    Página :432-432

    V. Krjukov, M. Yurkin

    
  • ·P03.403 Using of the scale derogatis (SCL-90) to diagnose affective disorders

    Página :432-432

    T. Yudeeva, G. Petrova, T. Dovzhenko

    
  • ·P03.404 Therapy of sexual somatization disorders in males

    Página :432-432

    I. Kan

    
  • ·P03.405 Thyroliberin in complex therapy in depressive patients

    Página :432-433

    G. Ivanova

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.406 Pharmacoeconomics of some depot neuroleptics and novel neuroleptics

    Página :433-433

    I. Gurovich, E. Lyubov, A. Shmukler

    
  • ·P03.407 Experience of sexual education of the adolescents

    Página :433-433

    T.N. Grigoryewa, N.N. Steniayewa

    
  • ·P03.408 Mental disorders in acute period of brain concussion

    Página :433-433

    I.V. Dorovskikh

    
  • ·P03.409 Basic remission of heroin dependence: Complex approach

    Página :433-434

    V.A. Galkin

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.410 The influence of the hormonal preparations (zoladex, tamoxiphen) on the clinic and the dynamics of the psychic disorders of the patients with breast cancer

    Página :434-434

    E. Boldova

    
  • ·P03.411 Depressive disorders developing after ovarioectomia

    Página :434-434

    G.Ya. Kamenetstkaya, V.N. Krasnov, S.V. Yureneva, N.G. Pilyaeva

    
  • ·P03.412 Sexual disorders in men-partners of women with vaginism and dispareunia

    Página :434-434

    A. Irina

    
  • ·P03.413 Correction of neurocognitive dysfunction in psychoorganic patients

    Página :434-435

    E. Kosterina, V. Krasnov

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.414 Psychopharmacotherapy of depression in primary care

    Página :435-435

    V. Krasnov, T. Dovjenko, Yu. Rivkina

    
  • ·P03.415 Antioxidant effect of cerebrolysin therapy of psychoorganic syndrome

    Página :435-435

    N. Yermackova, V. Krasnov

    
  • ·P03.416 The experience of practical use of the I-structural G. Ammon test with psychiatric hospital patients

    Página :435-435

    B.S. Polozhy, I.O. Khroulenko-Varnitsky

    
  • ·P03.417 The use of I-structure ista G. Ammon test in psycho-diagnostic research with patients of psychiatric hospital

    Página :435-436

    I.O. Khroulenko-Varnitsky, B.S. Polozhy

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.418 Somatic and neurological complications in drug addicts

    Página :436-436

    I.Y. Kaplan, A.A. Kozlov

    
  • ·P03.419 Symbiosis of psychiatry and neurocomputing, results, problems, perspectives

    Página :436-436

    A.G. Lee, V.D. Zigancov

    
  • ·P03.420 Videocourses on psychiatry

    Página :436-436

    A.G. Lee

    
  • ·P03.421 Antidepressants in heroine addiction treatment

    Página :436-437

    T.A. Kitkina, M.L. Rokhlina

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.422 Computerized assessment of depressive disorders severity

    Página :437-437

    E. Grigorieva

    
  • ·P03.423 Risk factor for psycopathology during residency (postgraduate medical training)

    Página :437-437

    P. Morales, O. Granada, G. Guerrero, J. Lopez-Ibor

    
  • ·P03.424 The most common psychopathological entities at refugees

    Página :437-437

    M. Pejovic, T. Cavic

    
  • ·P03.425 Emergency psychiatry at department for children and adolescent psychiatry — two years follow up

    Página :437-438

    M. Pejovic Milovancevic, N. Ljubomirovic

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.426 Resistant neurotic disorders

    Página :438-438

    N.A. Mauta, V.D. Mishiev, I.A. Yavdak, D.M. Denisenko

    
  • ·P03.427 Prophylaxis of the auto-aggressive behavior among military men of the forces of the ministry of internal affaires of Ukraine

    Página :438-438

    N.A. Maruta, V.S. Gichun

    
  • ·P03.428 Comparison of personality between Japanese major depressive and bipolar patients by the Munich personality test

    Página :438-439

    K. Otsuka, S. Kato

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.429 A comparison of diagnoses according TOGMS-A/AGECAT, DSM-III-R and clinician's definition

    Página :439-439

    R.T. Schaub, M. Linden, J.R.M. Copeland

    
  • ·P03.430 The severity and patterns of use of psychotropics drugs in non-fatal selfpoisoning

    Página :439-439

    G. Mandic-Gajic, T. Zujovic, R. Samardzic, Z. Spiric, B. Miljanovic, M. Preradovic

    
  • ·P03.431 Multi family discussion group in eating disorder integrated treatment

    Página :439-439

    A. Mei, M. Riccio, G. Faragalli, A. Ciocca, S. De Risio

    
  • ·P03.432 Comparison between SCL90R and S.C.I.D. I in eating disorders patients

    Página :440-440

    M. Riccio, G. Faragalli, A. Mei, A. Ciocca, S. De Risio

    
  • ·P03.433 Treatment of somatophorm disorders in Russian' hospitals

    Página :440-440

    V.N. Prokudin, A.P. Muzychenko, P.I. Sharaev, L.L. Khoundanov

    
  • ·P03.434 Psychiatric comorbidity among drug addicts: Evaluation of prevalence rate and creation of a network of intervention

    Página :440-440

    L. Di Furia, F. Scivittaro, M. Rizzo, F. Schifano, M. Sgrò

    
  • ·P03.435 Complex treatment of emergency conditions in patients with drug addiction

    Página :440-441

    N. Epifanova, A. Koukchina, I. Epifanov

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.436 Clinical symptoms among female and male drug-naive schizophrenic patients

    Página :441-441

    B.J. Havaki-Kontaxaki, V.P. Kontaxakis, S.S. Stamouli, C.T. Kolhas, G.N. Christodoulou

    
  • ·P03.437 Are regional suicide rates mirrored in subsequent national political changes?

    Página :441-441

    M. Voracek, A.K. Formann, G. Sonneck

    
  • ·P03.438 An acid test for nostradamus: Total eclipse of the sun 1999 and suicide incidence

    Página :441-441

    M. Voracek, G. Sonneck

    
  • ·P03.439 Suicidal behavior in prison inmates: Prospective Austrian national data 1996–1999

    Página :441-442

    M. Voracek, O. Bemecker, G. Sonneck

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.440 Depressive disorders and anxiety disorders in patients dialysed due to chronic renal insufficency

    Página :442-442

    G. Sikora, A. Klimowicz

    
  • ·P03.441 Influence of alcohol and alcoholism on criminal offences

    Página :442-442

    T. Žarkovic Palijan, M. Kovac, D. Kovacevic

    
  • ·P03.442 Impaired conditional discrimination learning in patients with social phobia

    Página :442-442

    G. Sachs, K. Dantendorfer, P. Anderer, M. Eberstaller, B. Saletu, H. Katschnig

    
  • ·P03.443 ADAS-COG (Alzheimer's Disease Assessment Scale-Cognitive subscale)-validation of the Slovak version

    Página :443-443

    E. Kolibáš, V. Kořínková, V. Novotný, D. Hunáková, K. Vajdičková

    
  • ·P03.444 A study in infertility: Psychodynamic and psychological evaluation of women undergoing IVF treatment

    Página :443-443

    M. Chatziandreou, G. Vaslamatzis, D. Kakatsaki, U. Dafni, D. Loutradis, M. Markidis

    
  • ·P03.445 Personality's features in eating disorders

    Página :443-443

    M. Bel, I. Jódar, M. Márquez, V. Fabregat, D. Palao

    
  • ·P03.446 Adopted image of disease as the basic psychological phenomenon of the therapeutic alliance with schizophrenic and depressive patients

    Página :443-444

    X. Solozhenkina

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.447 Secondary brain damage with HIV/AIDS

    Página :444-444

    J. Potribná, J. Kolčáková

    
  • ·P03.448 Neurasthenia-chronic fatigue syndrome. The basis and the meaning of medication and other therapy

    Página :444-444

    L. Janu, I. Prusa

    
  • ·P03.449 Profile of therapeutic action of mexidol in patients with organic brain injury

    Página :444-444

    I.A. Davydova

    
  • ·P03.450 Pharmachotherapy and psychotherapy of depressive disorders

    Página :444-445

    G.S. Bannikov

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.451 Antidepressants from different chemical groups in treatment of moderate and severe depression: Clinical and neurophysiological actions

    Página :445-445

    A. D'yakonov

    
  • ·P03.452 New approach towards a classification of organic brain disorders according ICD-10

    Página :445-445

    J. Kafka, E. Pálová

    
  • ·P03.453 Features of clinical patterns of suicidal behaviour in mental ill patients with post-traumatic brain lesions

    Página :445-445

    Z.R. Zulkarneeva, R.R. Khamitov

    
  • ·P03.454 Depression reduces the health-related quality of life

    Página :445-445

    S. Simo, K.S. Jouko, T. Tuula

    
  • ·P03.455 Psychiatric disorder in mentally retarded adolescent inpatients

    Página :446-446

    V. Tort-Herrando, M.E. Navarro-Hurtado

    
  • ·P03.457 Artistic production of a group schizophrenic patientes

    Página :446-446

    M. Krsmanović, Č.D. Miljević

    
  • ·P03.458 Behavioral and psychological symptoms of dementia

    Página :446-446

    K. Soltys, L. Bidzan

    
  • ·P03.459 Psychotherapeutic models of anxiety. depressive somatization disorders

    Página :446-446

    V. Solozhenkin, A. Kim

    
  • ·P03.460 Ethnoculturally oriented psychotherapy of anxiety and panic disorders in Kyrgyzstan

    Página :447-447

    V. Solozhenkin, T. Nelubova

    
  • ·P03.461 Dependent behaviors and psychotropic drug consumption

    Página :447-447

    P. Bizouard, S. Nezelof, Y. Taccoen, M. Corcos, J.L. Venisse, F. Perez-Diaz, O. Halfon, G. Loas, F. Lang, M. Flament, Ph. Jeammetz

    
  • ·P03.462 Open trial with milnacipran to assess efficacy, tolerability and quality of life

    Página :447-447

    A. Zoghlami, B. Schmid-Siegel

    
  • ·P03.463 A movement therapy group for mild demented and depressive patients — Description of an intervention

    Página :447-448

    I. Abramovici, N. Ashkenazi

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.464 Atypic antypsychotics in the treatment of both cognitive and behavioural deficiency of dementia

    Página :448-448

    L. Tarricone

    
  • ·P03.465 Pharmacotherapy of the DOC resistant

    Página :448-448

    L. Tarricone

    
  • ·P03.466 Association of apolipoprotein E and alpha2macroglobulin with alzheimer disease in Czech population

    Página :448-448

    A. Howardova, B. Rypackova, R. Jirak

    
  • ·P03.467 Development of the ptsd symptoms under the condition of the specific traumatic event

    Página :448-449

    G. Grbesa, M. Popovic, M. Simonovic

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.468 Modes of adaptation to prolonged stress in individuals with dependent and passive aggressive personality disorders

    Página :449-449

    N. Caran

    
  • ·P03.469 Depression and anxiety in pre-menstrual syndrome

    Página :449-449

    S. Tosic, S. Miljkovic, N. Golubovic

    
  • ·P03.470 Quantitative assessment of war-related stressors and a level of distress: A stuot study

    Página :449-450

    V. Jovic, D. Lecic-Tosevski, D. Savic, G. Knezevic, L. Tenjovic, G. Opacic

    Resumen Resumen Esquema Esquema

• Symposia

  • ·P03.472 Prognosis of remission in paranoid schizophrenic patients

    Página :450-450

    N.V. Govorin, T.P. Zlova

    
  • ·P03.473 Outcome in panic disorder

    Página :450-450

    S. Gariboldi, C. Cimmino, C. Balista, M.E. Menini, G. Paulillo, M. Amore, C. Maggini

    
  • ·Author index

    Página :451-463

    Resumen Resumen Esquema Esquema